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In this work we developed paper spray mass spectrometry methods to obtain lower 
detection limits for pharmaceuticals and drugs of abuse.  The second chapter investigates blood 
fractionation membranes for their ability to obtain lysis free plasma from whole blood without 
changing the drug concentration relative to centrifugation.  We presented a device capable of 
obtaining and analyzing plasma samples from whole blood and obtaining quantitative results 
similar to traditional methods.  In the third chapter the properties of the paper substrate are 
investigated systematically for their impacts on ionization efficiency and recovery in combination 
with the solvent choice.  The fourth and fifth chapters detail a simple method for lowering detection 
limits using a method called paper strip extraction.  In this method biofluids are wicked through 
either sesame seed oil or solid phase extraction powder on a paper strip to concentrate and preserve 
(in the case of THC) analytes out of biofluids.  The use of 3D printing for rapid prototyping and 
how it potentially impacts paper spray MS sensitivity is outlined in the final chapter. 
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 INTRODUCTION 
1.1 Mass Spectrometry and Ionization 
 Mass spectrometry depends on two components: ionization, where molecules are evolved 
into the gas phase and charged into ions; and detection, where ions are separated and detected 
based on their mass and charge.  The technique dates back over one hundred years to the work of 
J. J. Thomson and his apparatus for deflecting gas phase ions using electric and magnetic fields 
based on their charge to mass ratio1.  Using this apparatus Thomson was able to detect multiple 
charge states of hydrogen, and proved the existence of isotopes by detecting 20Ne and 22Ne 1.  A 
more efficient mass spectrometer, which uses a magnetic field to deflect ions in a parabolic path 
came about several years later in the lab of F. W. Aston, who was Thomson’s student2.  Aston used 
this instrument to investigate over 50 elements and found that isotopes tended differ in mass to 
charge by nearly whole number increments2.  Concurrently, in the lab of A. J. Dempster a similar 
mass spectrometer was built, but, with a gas discharge ion-source that could generate ions in a 
more reproducible fasion3. 
 Modern mass spectrometers employ a variety of techniques for separating and detecting 
ions.  These range from low resolution instruments, such as the linear ion trap developed by Church 
in 19694, to high resolution instruments like the orbitrap invented by A. Makarov in 2005.  The 
orbitrap is capable of 5 part per million mass accuracy (how close the mass to charge measurement 
is to the true value; 5 part per million is within 0.0005% of the true value) and up to 150,000 
resolution (how well the instrument is capable of differentiating molecules with similar masses; 
150,000 resolution means that the instrument can distinguish between molecules with a 0.001 amu 
mass difference at 150 amu molecular mass)5.  Mass spectrometers analyze ions by separating 
them using magnetic or electric fields, then measuring them by either sending the ions to a 
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detector6, employing a sensor to detect the frequency of oscillation of trapped ions5, or both.  For 
example, ion trap mass spectrometers use electric fields to trap ions then eject them to mass 
analyzers for detection.  In contrast, orbitraps trap ions in a chamber with specialized geometry 
and establish a pattern of movement for the ions.  Ions separate into distinct regions, so that the 
frequency of the ions can be measured by the induced current.  These modern spectrometers use 
different methods, but ultimately, they all measure mass to charge.   
At the interface, where molecules enter the mass spectrometer, is the ionization source.  
The purpose of the ionization source is to get molecules into the gas phase and charged.  In early 
mass spectrometers, the elements being analyzed were already a gas1, and they were ionized by a 
beam of electrons through a process called electron ionization(EI)3.  As the high energy electrons 
interact with the gas phase molecules, a thermal electron is removed from the molecule.  This 
results in positively charged radical cations, which often have excess internal energy2.  The excess 
imparted energy frequently causes the molecule to break apart into smaller pieces, a process called 
fragmentation.  Positively charged intact and fragmented ions enter the mass spectrometer and are 
measured based on both their mass to charge and their relative abundance.  Modern mass 
spectrometers often contain means to fragment the ions further, often through the impact of the 
molecules with chemically inert gas molecules such as nitrogen or helium.  The measured mass to 
charge and relative abundance of all the ions and fragments is called a mass spectrum.  Because 
molecules tend to fragment reproducibly when using the same type of ionization and fragmentation, 
the mass spectrum of fragment ions can be used to identify the original molecule.  This is useful 
for fields that require identification of unknown molecules such as medicine for toxicology 
screening, or in forensic science for drug of abuse screening7-8.   
16 
 
 
 
Since the original experiments in mass spectrometry, a variety of methods for ionizing 
molecules have been developed to accommodate samples in different physical states, and to vary 
how much the ions are fragmented.  In Thomson’s early work, solid phase samples were initially 
ionized by hitting the surface with a beam of electrons to evolve gas phase ions1.  One of the major 
drawbacks of electron ionization is its tendency to heavily fragment ions, also known as hard 
ionization.  Softer techniques came about later; Munson and Field in 1966 developed chemical 
ionization (CI), where a reagent gas is ionized which then ionizes the gas phase molecules without 
heavy fragmentation9.  Other ionization methods were developed for solid state samples such as 
secondary ion mass spectrometry (SIMS) in the 1960’s by Liebl10 and Castaing11, fast atom 
bombardment (FAB) by Barber in 198012, or liquid SIMS (LSIMS) by Hass in 198413.  Both SIMS 
and FAB have been largely replaced by matrix assisted laser desorption ionization (MALDI).  
Developed in 1985 by Hillenkamp and Karas14, MALDI involves a solid matrix consisting of a 
reactive compound mixed with the sample that is excited with a laser to generate gas phase ions. 
Modern day mass spectrometers are often paired with either liquid or gas chromatography 
to separate the components of a sample prior to introduction to the mass spectrometer.  The type 
of chromatography often determines what type of ionization method is used.  For example, gas 
chromatography, which already utilizes gas phase molecules, often uses EI because of its ease of 
use and reproducible fragmentation, which enables mass spectral libraries (spectral databases).  
Initially, liquid chromatography posed problems because it introduced a large volume of solvent 
that had to be removed to generate gas phase ions at ambient atmospheric pressure.  Atmospheric 
pressure ionization (API) using corona discharge was developed by Horning and Carroll in the 
1970’s15-16, which incorporated a stream of gas to help remove solvent from molecules.  
Atmospheric pressure techniques were further refined in the 1980’s and lead to some of the most 
17 
 
 
 
prevalent techniques used today, including atmospheric pressure chemical ionization (APCI) 
developed in 198717 and electrospray ionization (ESI) by Fenn in 198918.  APCI, similar to CI, is 
a soft ionization method where a gas such as N2 is charged and reacted with solvent molecules that 
further react with analytes in the gas phase to produce ions.  ESI involves charging the solvent 
with a high voltage relative to the inlet of the mass spectrometer.  The large difference in potential 
causes the solvent to spray in a cone of droplets, known as a Taylor cone, toward the inlet.   The 
charged droplets become smaller as the solvent evaporates; when they reach the point where there 
is too much charge for its volume, called the Rayleigh limit, further fission occurs.  Eventually, 
either through fission or evaporation, molecules are left in the gas phase with a charge from a 
chemical agent that either adds or removes a proton.  Using these techniques, a sample can be 
separated into its individual components which can be analyzed separately. Chemical specificity 
is achieved through both the retention time (how long it takes for a component to go through the 
chromatography column) as well as its mass spectrum. 
1.2 Ambient Ionization 
Chromatography is a useful technique but increases the analysis time per sample and requires 
a significant investment of resources to maintain.  Ambient ionization, direct analysis of an 
unmodified or minimally modified surface or sample under atmospheric conditions, forgoes 
chromatography to directly analyze a sample.  The first two examples were desorption electrospray 
ionization (DESI) in 200419 and Direct analysis in real time (DART) in 200520.  In both cases, a 
sample is placed near an inlet of a mass spectrometer for direct analysis using either a spray of 
charged solvent for DESI or a stream of charged gas for DART to generate ions.  Since the 
introduction of DESI and DART, a variety of new techniques have emerged21.  These techniques 
primarily differ in how they generate gas phase ions.  For example, both laser ablation electrospray 
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ionization (LAESI)22 and electrospray-assisted laser desorption/ionization (ELDI)23 utilize lasers 
to impart energy and generate gas phase ions while surface acoustic wave nebulization (SAWN)24 
uses acoustic waves.  Another option includes applying solvent and voltage to a porous surface to 
generate electrospray as in paper spray25-26.  The field of ambient ionization has grown 
substantially in 15 years, with over 40 methods for directly analyzing surfaces and samples in the 
literature since the advent of DESI in 2004.   
Ambient ionization can rapidly acquire information; however, the lack of sample preparation 
presents problems to analysis.  Often the surface or sample being analyzed is complex, with non-
analyte species present at high concentrations.  For example, blood contains proteins, lipids and 
salts present at concentrations that are much higher than the analyte of interest.  These matrix 
components can lead to a complicated mass spectrum, and can cause matrix effects. Since the 
analytes of interest must be freed from the matrix and compete for ionization during analysis27, 
poor recovery and ionization efficiency are common problems to overcome.  Tandem mass 
spectrometry (MS/MS) can improve selectivity by fragmenting specific parent ions and measuring 
diagnostic fragments unique to the analytes of interest, but matrix effects still increase detection 
limits.   
1.3 Paper Spray Mass Spectrometry 
Paper spray mass spectrometry (MS), developed in the Cooks lab in 2010, involves spotting 
a biofluid on a triangle of paper and applying solvent and voltage to generate a plume of charged 
solvent droplets, known as a Taylor cone, similar to electrospray ionization (Figure 1.1)25-26.  The 
solvent wicks through the biofluid spot and extracts analytes, so they can go from the biofluid to 
the gas phase in minimal time.  Paper spray-MS has been used to obtain rapid results for monitoring 
therapeutic and recreational drugs, lipids, proteins, explosives, and biomarkers27.  The technique 
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has also been expanded to spray off a variety of porous non-paper matrices like wood28, leaves29 
and threads30 and has been combined with other techniques such as Raman31, so that one sample 
can be used to obtain a Raman spectrum in addition to a mass spectrum.  Quantitation down to 
ng/mL and sub-ng/mL ranges has been achieved for many analytes through use of stable isotopic 
labels (SIL) of analytes as internal standards32-35.  In recent years efforts to improve detection limits 
of paper spray-MS have included using a solid phase extraction step integrated in a paper spray 
cartridge36 or conducting a liquid-liquid extraction on top of hydrophobic paper37. Through these 
techniques the detection limits for paper spray-MS can be regularly lowered to sub-ng/mL 
detection limits. 
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Figure 1.1: Paper Spray Mass Spectrometry.  Solvent and voltage applied to a wedge of paper 
containing a dried biofluid to generate a Taylor cone in front of a mass spectrometer inlet.  
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Paper spray MS has advantages over traditional drug screening methods such as immunoassays.  
Developed by Berson and Yalow in 195938, IAs employ an antibody to a specific analyte and an 
indicator that has a distinct color change when antibody binds the target molecule.  However, these 
tests have several drawbacks, such as poor selectivity due to the antibody binding molecules with 
a similar structure39, poor sensitivity for low concentration analytes in complex matrices, and 
limited ability to multiplex or detect multiple analytes simultaneously40.  Paper spray-MS has been 
shown to have detection limits at biologically relevant concentrations in a variety of biofluids26. 
Multiplexing is also easier; paper spray MS has been shown capable of detecting over 130 drugs 
and their metabolites simultaneously during a single 2.5 minute analysis41.   
Rapid analysis through paper spray-MS is useful for applications such as therapeutic drug 
monitoring (measuring a therapeutic drug to ensure effective and non-toxic dosage) and the newer 
problem of detecting new psychoactive substances (NPS) (new drugs that mimic more well-known 
drugs in function but have distinct molecular structures).  Monitoring drug concentrations in a 
patient is important, as each patient will metabolize the drug at a different rates42.  Tacrolimus and 
cyclosporin, immunosuppressive drugs used to prevent rejection of transplanted organs, are 
routinely monitored in clinical settings because there is a narrow window between the effective 
concentration of the drug and the concentration at which the drug is toxic. A method has been 
developed with paper spray-MS, and it has been shown measurable using paper spray-MS with 
accuracy comparable to traditional HPLC-MS methods32, 43.  Paper spray-MS also shows promise 
for dealing with NPS (Figure 1.2).  These compounds, often developed during pharmaceutical 
research, are similar to normal drugs of abuse in structure or function44.  Since NPS’ are new with 
limited available data and can have extremely high potency with unknown side effects, they pose 
an acute health risk to their users.  For example, opioids like fentanyl and carfentanil have 
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potencies approximately one hundred and one thousand times respectively than that of the 
historically more common heroin45.  This wide range of potency has played a major role in the 
recent surge of opioid related deaths in the United States46.  Another problem associated with NPS 
is the large number of possible target analytes.  Synthetic cannabinoids, come from an extensive 
selection of compounds and are sprayed on dried plant matter that is marketed as incense “not for 
human consumption47.”  With a poor understanding of potency, dosage, and side effects it is not 
uncommon for people to end up in the emergency room without knowing the exact compound that 
they took.  High potency at lower than normal concentrations and large number of potential targets 
are a challenge for traditional immunoassays but can be dealt with through paper spray-MS.  Paper 
spray allows samples to be spotted and ionized within minutes, while mass spectrometry has the 
capability to differentiate between a wide variety of analytes simultaneously based on their unique 
spectrum. 
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Figure 1.2: Examples of New Psychoactive Substances:  AB-CHMINACA and AM-2201 are 
synthetic cannabinoids that mimic tetrahydrocannabinol in function.  Acetylfentanyl and 
carfentanil are analogues of fentanyl. 
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The focus of this dissertation is to improve paper spray-MS, particularly its ease-of-use.  Several 
problems still stand in the way of adoption of paper spray-MS for clinical applications.  A major 
issue is that current protocols for monitoring drugs in biofluids focus on the concentration in 
plasma48, which adds an extra centrifugation step for paper spray analysis.  The first chapter 
details work on a paper spray cartridge that can obtain plasma from whole blood, with minimal 
red blood cell lysis and without changing the concentration in plasma relative to plasma obtained 
by centrifugation.  Separating out plasma from whole blood only addresses one concern for one 
biofluid.  A problem for analysis of any biofluid remains the presence of matrix components, 
which can lead to poor recovery and ionization efficiency27.  In the second chapter a variety of 
papers with varying physical properties are investigated to determine what impact those 
properties have on matrix effects during paper spray-MS, and whether paper can be selected for 
its impacts on matrix effects to lower detection limits.  Detecting NPS’ is covered in the third 
and fourth chapters.  For example, tetrahydrocannabinol (THC) is the active ingredient in 
marijuana and can significantly impact driving capabilities49-51 and it represents a very labile and 
difficult analytical target52 for paper spray-MS.  The third chapter focuses on preserving and 
concentrating natural cannabinoids for detection along with synthetic cannabinoids in urine and 
oral fluid.  The fourth chapter is dedicated to finding more facile methods of using solid phase 
extraction powder to concentrate a wider selection of designer drugs from urine, oral fluid, blood 
and plasma.  This is accomplished both by coating the powder onto the end of a strip of paper 
and by immobilizing the powder in an autosampler cartridge.  The final chapter focuses on the 
use of 3D printing in research on paper spray-MS with a focus on how the plastic potentially 
impacts detection limits.  A brief discussion on how to select the proper plastic when printing a 
device concludes the final chapter.  
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 ON-CARTRIDGE BLOOD FRACTIONATION FOR 
DRIED PLASMA ANALYSIS BY PAPER SPRAY MASS 
SPECTROMETRY 
2.1 Abstract 
 Drug monitoring of biofluids is often time consuming and prohibitively expensive.  
Analysis of dried blood spots offers advantages, such as reduced sample volume, but can require 
extensive sample preparation and trained lab technicians.  Alternatively, paper spray mass 
spectrometry allows for rapid analysis of small molecules from blood spots with minimal sample 
preparation.  Plasma is often the preferred matrix rather than blood for bioanalysis; however, 
centrifugation is required to remove red blood cells which adds time and cost.  We demonstrate 
here a paper spray cartridge containing a plasma fractionation membrane to obtain plasma from 
whole blood samples. Three commercially available blood fractionation membranes were 
evaluated based on the accuracy of the drug concentrations in the plasma and the extent of cell 
lysis/penetration.  The accuracy of the plasma concentrations in membrane fractionated plasma 
was evaluated using high performance liquid chromatography – mass spectrometry.  While the 
fractionation membranes were capable of yielding plasma samples with low levels of cell lysis, 
the membranes exhibited drug binding to varying degrees relative to plasma obtained by 
centrifugation. Using the membrane exhibiting the lowest binding we developed a simple paper 
spray cartridge capable of obtaining a reproducible volume of plasma from whole blood. 
Quantitative analysis of the plasma samples by paper spray MS yielded similar results to HPLC-
MS, but without the need for an offline extraction step or chromatography.  
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2.2 Introduction 
 For certain drugs, it is critical to monitor concentrations within the body.  There is a 
therapeutic window at which the drug is most effective without causing adverse side effects such 
as organ toxicity, neurological effects, and hepatoxicity1-2.  However, every patient metabolizes 
drugs at different rates, making dosing difficult3.  Monitoring drugs in blood can be expensive due 
to extra sample preparation steps such as centrifugation and protein precipitation as well as the 
extra cost in shipping refrigerated samples.  This has led to a constant push towards analytical 
techniques that are both rapid and cost effective with minimal sample preparation and analysis 
requirements. 
Because of its simplicity and low cost, paper spray mass spectrometry (MS) shows 
potential for point of care analysis4-6.  Paper spray MS has been shown to be useful in the 
quantitation of a wide variety of pharmaceuticals including immunosuppressive drugs such as 
tacrolimus and cyclosporine7-8 and illicit drugs9-11.  One limitation for paper spray is that, while 
whole blood is easier to obtain, it is the plasma concentration that is often desired12.  In general, 
the use of plasma instead of blood is more readily accepted in pharmacokinetic studies13.  This is 
especially true for antipsychotic drugs where drug plasma concentration correlates to blocked 
receptors and efficacy14.  Another concern is inaccuracy caused by variable hematocrit or red blood 
cell percentage of the whole blood15.  Adding a centrifugation step to obtain plasma, however, 
would increase the method’s complexity which adds time and cost to each sample.  Several 
methods for obtaining plasma from whole blood without resorting to centrifugation have been 
reported using methods ranging from acoustics16 to labyrinth like mazes17.  These methods are 
able to provide plasma with minimal effect on the matrix, but, are too complex for an inexpensive 
disposable collection device.  Blood fractionation membranes are a potential low cost solution.  
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These membranes can be used to obtain plasma from whole blood while still yielding accurate 
drug concentrations in specific cases18,19.  
 Here we investigate the use of three plasma separation membranes for small molecule drug 
analysis.  Using HPLC-MS, the membranes were evaluated based on their ability to obtain 
hemolysis free plasma and not interfere with small molecule drug concentrations.  The membranes 
were then incorporated into a simple paper spray cartridge to enable direct plasma analysis from a 
drop of whole blood.  Agglutinating agents, compounds that induce blood cell clumping, were also 
added to the membranes to determine if blood fractionation could be improved without 
contributing to drug binding.  Finally, the results from the plasma fractionation cartridge using 
paper spray MS were compared to HPLC-MS to determine whether accurate results could be 
obtained in a shorter amount of time. 
2.3 Materials  
 Atenolol, carbamazepine, fentanyl, methadone, nortriptyline, selegiline, chlorpheniramine, 
cotinine, alprazolam, diazepam and their stable isotopic labels (SIL), except atenolol D7, were 
obtained from Cerilliant (Round Rock, TX, U.S.A.).  Atenolol D7 was obtained from CDN 
isotopes (Pointe-Claire, QC, Canada) as a powder (≥98% purity).  HPLC grade methanol, 
acetonitrile, formic acid and acetic acid came from Fisher Scientific (Waltham, MA, U.S.A).  Five 
individual donor human blood samples came from Innovative Research in K2EDTA treated vials 
(Novi, MI, USA).  NoviPlex cards were obtained from Novilytic (West Lafayette, IN, U.S.A.), 
while CytoSep and Vivid blood fractionation membranes were obtained from the Pall Corporation 
(Port Washington, NY, U.S.A.).  The holder that contained the Vivid membrane was 3D printed 
using a Stratasys Objet 30 pro using VeroBlue photopolymer (Eden Prairie, MN, U.S.A).  The 
paper spray cartridges and other sample holders were machined out of Delrin and HDPE plastic 
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respectively (McMaster-Carr) (Elmuhurst, IL, U.S.A.) on a bench-top mini milling machine 
(Sherline - Vista, CA, U.S.A.).  Whatman grade 31 ET chromatography paper was used for the 
spray substrate and sample storage (GE Healthcare Life Sciences - Pittsburgh, PA, U.S.A.).  
Human fibrinogen (50-70% protein), alum (aluminum potassium sulfate dodecahydrate ≥98% 
purity), carbamazepine powder (≥98% purity), and NaCl were obtained from Sigma-Aldrich (St. 
Louis, MO, U.S.A.).  
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Figure 2.1: Examples of Different Methods of Blood Fractionation.  Sample punches dyed green 
for contrast.  (A) Sample holder for the vivid membrane (left to right): holder with the sample 
punches, 13 mm square of vivid membrane, and closed holder with membrane inside (B) 
Noviplex extraction card with sample punches. (C) Left: diagram of delrin tube used to contain 
the 4 squares of CytoSep membrane.  Right: picture of the Delrin tube inside the holder with the 
CytoSep membranes in the tube. 
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2.4 Methods 
2.4.1 Plasma Separation 
 Each type of membrane required a different set up to extract plasma from whole blood 
(Figure 2.1).  Extracted plasma was collected on 3 mm punches of Whatman 31ET filter paper.  
The Vivid GR membrane (Figure 2.1A) was prone to ripping so a special holder was 3D printed 
to contain the punches and a 13 mm x 13 mm membrane.  When the top piece of the holder was 
put into position, it forced the membrane into a bowl shape.   Extraction involved adding 40 µL of 
whole blood to the membrane bowl and allowing 3 minutes for the plasma to wick through. The 
NoviPlex plasma extraction card (Figure 2.1B) was already designed to be a self-contained 
sampling device and was used without modification except the sample disk was replaced with 
three Whatman 31ET punches.  A 30 µL aliquot of whole blood was added to the top layer 
followed by 3 minutes of sitting to allow the plasma to wick through to the sample punches.  The 
CytoSep membrane was assembled inside of a disposable tube by inserting four 5 mm x 5 mm 
squares of grade 1660 membrane one at a time (Figure 2.1C).  Four stacked membranes were 
required to improve plasma fractionation.  The disposable insert was made of a 9 mm length of 
Delrin tube (3.175 mm inner diameter) with a piece of wax paper with a small hole in it glued over 
the bottom.  To obtain plasma, the insert containing the membranes and wax paper was placed in 
a tightly fitted plastic holder with a sample punch beneath (Figure 2.1C).  Whole blood was applied 
to the top of the insert and plasma wicked through over 15 minutes.  Each sample punch was 
weighed before and after sample was applied to obtain the mass of the plasma.   
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2.4.2 Preparation of Bio-fluids, Calibrators, and Controls 
 The samples for HPLC-MS/MS were prepared using five different lots of blood at two 
concentrations: 1.5 µg/mL and 0.3 µg/mL for each drug.  Each blood sample was taken through 
the three different membranes in triplicate.  Drug stock solutions were diluted to working solutions 
in 0.6 mg/mL aqueous saline before being spiked into whole blood to minimize solvent based cell 
lysis. All spiked blood samples had a maximum methanol content of 1.5% (v/v). Samples were 
incubated at least 1 hour at 37°C prior to fractionation and were applied to the membrane while 
still warm.  Samples were allowed to dry for 1 hour at room temperature in open air to dry.  Plasma 
control samples were prepared by centrifuging an aliquot of the blood at 1500 rpm for 30 minutes. 
    Calibrators and controls were prepared in pooled drug free plasma from the five blood 
donors.  The calibration curve was prepared by spiking the pooled plasma with of atenolol, 
carbamazepine, fentanyl, nortriptyline and methadone at concentrations of 0.03 µg/mL, 0.1 µg/mL, 
0.3 µg/mL, 1 µg/mL and 3 µg/mL for each compound. A control sample was prepared separately 
at 1 µg/mL for each drug to verify the validity of the calibration curve.  Calibrators and controls 
were spotted on paper punches at 2.3 mg, the average mass of plasma obtained during fractionation. 
Calibrators were run in duplicate, and a control was run every 10 samples. 
2.4.3 HPLC-MS/MS 
 Dried sample punches were transferred to a 500 µL centrifuge tube containing 100 µL of 
extraction solvent (15% methanol by volume in water containing 0.1 µg/mL each of atenolol D7, 
carbamazepine D10, fentanyl D5, nortriptyline D3 and methadone D3) and were vortexed for 30 
minutes.  The sample punches were then removed, and the solutions centrifuged at 3000 rpm for 
5 minutes.  An 80 µL aliquot was transferred to an HPLC vial from each sample for analysis.  
Analysis was carried out using an Agilent 1100 liquid chromatography system (Agilent 
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Technologies, Santa Clara, CA.) coupled to a Thermo Scientific LTQ XL mass spectrometer using 
a hypersil gold C18 column (Thermo Scientific, San Jose). The sample volume injected was 15 
µL.  The HPLC separation was a gradient elution (Solvent A was water with 0.01% formic acid, 
solvent B was methanol with 0.01% formic acid) at 200 µL/min. The gradient was as follows: 15% 
Solvent B for 2 minutes, followed by a linear increase to 80% Solvent B over 2 minutes, then to 
95% Solvent B over 1.2 minutes.  Solvent B was held at 95% for 4.5 minutes before being dropped 
and held at 15% for 5 minutes with a flow rate of 400 µL/minute for re-equilibration.  MS was 
conducted in positive ion mode using electrospray ionization (ESI).  The sheath and auxiliary gas 
flow rates were set to 20 and 5 arbitrary units respectively.  The instrument was operated in MS/MS 
mode with a spray voltage of 4.5 kV.  Measurements were obtained for a unique fragment of the 
[M+H]+ ion for each analyte and ratios were determined by dividing the peak area for the analyte 
by the peak area for the SIL.  The slope and y intercept for the curve for each drug was found using 
1/x weighted least squares20.  Because each of the three membrane types yielded a different mass 
of plasma, final concentrations obtained from the calibration curve were normalized based on the 
average mass of plasma obtained for each membrane type using equation 1: 
 
𝐶𝑓 = 𝐶𝑖 (
𝑀𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛
𝑀𝑠𝑎𝑚𝑝𝑙𝑒𝑠
) (1) 
 
where Cf is the final concentration, Ci is the concentration calculated obtained without normalizing 
the mass of the plasma calibrators, Mcalibration is the average mass of plasma spotted for the 
calibrators, and Msamples is the average mass of plasma obtained for a particular plasma 
fractionation method. Mcalibration  was 2.3 mg.  Msamples was 2.2mg, 2.8 mg, and 1.5 mg for the 
cytosep, vivid, and the noviplex membranes, respectively. 
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2.4.4 Paper Spray  
 Plasma fractionation and paper spray MS was carried out on a custom-built spray cartridge 
involving the CytoSep membrane (Figure 2.2).  The blood sample was applied to the removable 
tube, which contained the fractionation membranes in contact with a sample punch below the tube.  
When the punch was saturated after 15 minutes, additional plasma could not wick through and the 
tube insert was discarded.  An aliquot of 0.5 µg/mL SIL in methanol, with a volume equivalent to 
the average mass of extracted plasma (2.2 µL for CytoSep membrane), was spotted onto the dried 
plasma punch.  After drying, the paper disc containing the plasma sample was pushed down onto 
the spray substrate. 
 Analysis was performed by positioning the cartridge in front of an LTQ XL mass 
spectrometer with the paper tip 2.5 mm away from the MS inlet. A 30 µL aliquot of spray solvent 
(95:5:0.01 methanol:water:acetic acid) was pipetted on top of the sample disc, where it wicked 
through the sample and onto the spray substrate. Methanol based solvent gave low signal for 
cotinine so a spray solvent of 90:10:0.01 acetonitrile:water:acetic acid was used for those samples.  
A voltage of 4.5 kV was applied to initiate the plume of ions and remained on for 60 seconds.   
Analysis was carried out in MS/MS mode using the base peak fragment of the [M+H]+ for 
quantitation.  For experimental purposes, one spray cartridge was re-used for each analysis and 
sample preparation was conducted in a block of plastic with holes (Figure 2.1C).  Between runs 
the cartridge was cleaned with methanol and the spray substrate was replaced to reduce carryover. 
2.4.5 Determining Hematocrit and Membrane Induced Hemolysis 
 The five lots of blood were prepared by filling a 25 mm segment of a borosilicate glass 
capillary (0.86 mm inner diameter Sutter Instrument, Novato, CA) with blood followed by sealing 
the tube with paraffin wax and centrifuging at 1500 rpm for 30 minutes.  Hematocrit was calculated 
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by measuring the packed cell volume relative to the total sample volume.  A calibration curve was 
created by mixing whole blood (a mix of equal parts of all 5 lots of blood) with centrifuged plasma 
to make calibrants ranging from 0.45% to 9% (v/v) cellular material in plasma.  Blood cell content 
calibrators were dried and extracted in solvent as described for the HPLC samples. The extent of 
red blood cell lysis and penetration in the membrane fractionated plasma samples was measured 
by measuring the absorbance of the sample from the extracts at 413 nm using a Thermo Scientific 
NanoDrop 2000 spectrophotometer.    
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Figure 2.2: Schematic for Paper Spray Cartridge with Removable Blood Fractionation Insert.  
The plastic is Delrin and the sample punch and spray substrate are Whatman grade 31 ET filter 
paper.  
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2.4.6 Membrane Treatment to Improve Plasma Separation 
 Two different blood agglutination agents were investigated as membrane treatments to 
improve separation.  CytoSep membranes, treated with the protein fibrinogen at concentrations 
ranging from 20 to 1000 µg/mL, were tested for separation efficiency and potential drug binding.  
Fibrinogen solutions were spotted onto each membrane in four aliquots of 5 µL allowing roughly 
an hour between aliquots for drying at room temperature.  The non-protein based agglutinating 
agent alum was also tested at concentrations ranging from 20 to 60 µg/mL.  In the final 
configuration, only the top membrane in the stack was treated with 5 µL of 40 µg/mL fibrinogen. 
To determine if paper spray MS could be used to obtain quantitative results similar to that of 
HPLC-MS/MS, plasma that was extracted using membranes treated with human fibrinogen was 
compared to centrifuged plasma samples.  The curve and samples were prepared as described for 
the HPLC-MS/MS experiments.  The samples came from a single lot of blood with 7 replicates 
for the membrane separated samples (n=6 for the 1.5µg/mL samples due to an insert failure) and 
5 replicates for the centrifuged control samples. 
2.5 Results and Discussion 
2.5.1 Evaluation of Hematocrit, Plasma Mass and Lysis 
 Three commercially available plasma separation membranes (Vivid GR asymmetric 
polysulphone membrane, Noviplex blood fractionation card and Cytosep grade 1660 lateral blood 
fractionation paper) were evaluated for their ability to obtain reproducible amounts of red blood 
cell free plasma (Table 2.1).  Five lots of human blood with hematocrits ranging from 45 to 54% 
were evaluated.  The average mass of plasma was taken from 6 replicates of each blood lot and 
the percent volume of red blood cells was determined based off 1 replicate from each lot compared 
to a calibration curve.  Both the Vivid GR and Noviplex card showed good plasma fractionation 
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with a total red blood cell content below 1% (v/v).  The Cytosep grade 1660 membrane stacked 4 
high showed noticeably poorer separation at 6% red blood cells, most likely due to being a lateral 
flow membrane. 
 The CytoSep membrane was selected for further testing in combination with a cartridge 
that could obtain plasma from whole blood.  Ideally, the paper spray cartridge would be able to 
deliver a reproducible volume of plasma from poorly controlled blood sample volumes.  Volumes 
of blood ranging from 30 to 50 µL were applied to the treated membranes and it was found that 
the volume of blood had no effect on the extracted volume of plasma (Table 2.2).  This is likely 
due to the sample punch becoming saturated and preventing excess plasma from wicking through. 
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Table 2.1: Mass and Red Blood Cell Content of plasma Obtained by Three Membranes.   Average 
and 95% confidence interval for the wet plasma mass obtained for each membrane and average 
and 95% confidence interval red blood cell content in the plasma. 
 
 
 
 
Table 2.2: Mass of Plasma Obtained from Variable Blood Volumes Using Cytosep Membrane.   
The 95% confidence intervals for mass of plasma extracted from whole blood using fibrinogen 
treated CytoSep membranes from different volumes of whole blood (N=5). 
 
 
 
 
Table 2.3: Drug Concentrations in Plasma Obtained by Three Blood Fractionation Membranes.  
Averaged plasma concentrations in µg/mL from whole blood fractionated by three different 
membranes. 
 
Extraction method 
Mass of plasma 
(mg) 
Red blood cell % 
(v/v) 
CytoSep grade 1660 2.2±0.4 6±2 
Vivid GR 2.82±0.06 0.22±0.09 
Noviplex 1.53±0.04 0.8±0.2 
Volume of 
whole blood 
Mass of plasma 
extracted (mg) 
30 µL 2.7 ± 0.2 
40 µL 2.7 ± 0.2 
50 µL 2.7 ± 0.5 
 
Original 
Concentration 
CytoSep Vivid Noviplex Centrifuge 
Atenolol 
0.3 µg/mL 0.32 0.24 0.25 0.37 
1.5 µg/mL 1.66 1.08 1.17 1.67 
Carbamazepine 
0.3 µg/mL 0.26 0.11 0.16 0.32 
1.5 µg/mL 1.41 0.44 0.59 1.53 
Fentanyl 
0.3 µg/mL 0.24 0.08 0.24 0.35 
1.5 µg/mL 1.28 0.37 1.22 1.77 
Methadone 
0.3 µg/mL 0.21 0.16 0.23 0.47 
1.5 µg/mL 1.04 0.99 1.15 1.79 
Nortriptyline 
0.3 µg/mL 0.06 0.13 0.20 0.29 
1.5 µg/mL 0.36 0.54 1.06 1.51 
42 
 
 
2.5.2 Assessment of Drug Binding 
 Drug loss due to binding to the membrane was evaluated by measuring the drug 
concentration (Table 2.3) of the plasma obtained by membrane filtration and the percent decrease 
relative to centrifuged plasma (Table 2.4).  Calibrators and controls were prepared directly in 
plasma to ensure a known plasma concentration.  The experimental samples were prepared in 
whole blood as opposed to plasma to allow the drugs to distribute between the blood cells and the 
plasma to account for any changes in concentration caused by unequal distribution of drug.  
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Table 2.4: Decrease in Drug Concentration in Plasma Obtained Using Three Membranes.  The 
average % decrease in drug concentration relative to the concentration found in centrifuged 
plasma for three membranes at two concentrations. 
 Original 
Concentration 
CytoSep Vivid Noviplex 
Atenolol 
0.3 µg/mL -13% -36% -33% 
1.5 µg/mL 0% -36% -30% 
Carbamazepine 
0.3 µg/mL -17% -65% -51% 
1.5 µg/mL -8% -71% -62% 
Fentanyl 
0.3 µg/mL -31% -76% -31% 
1.5 µg/mL -28% -79% -31% 
Methadone 
0.3 µg/mL -55% -66% -50% 
1.5 µg/mL -42% -45% -36% 
Nortriptyline 
0.3 µg/mL -78% -57% -29% 
1.5 µg/mL -76% -64% -30% 
 
 
Table 2.5: Change in Drug Concentration in Plasma Obtained Using Treated Membranes.   
Change in concentration of drugs in plasma extracted using CytoSep grade 1660 membrane 
(both untreated and treated with alum or fibrinogen) relative to plasma obtained via centrifuge.  
NS indicates that the difference between the results for the control and experimental were not 
statistically significant (p>0.05). 
Drug logP KB/P 
Untreated 
(plasma) 
Untreated 
(blood) 
Fibrinogen 
(blood) 
Alum 
(blood) 
selegiline 3.08 1.7 -5% NS -26% -43% -21% 
chlorpheniramine 3.74 1.34 -5% NS -31% -46% -18% 
atenolol 0.57 1.07 8% NS -2% NS -8% NS -4% NS 
carbamazepine 2.1 1.06 13% NS 5% NS -3% NS -10% NS 
fentanyl 4.02 0.97 -3% NS -31% -24% -31% 
cotinine 0.39 0.88 -4% NS -15% -19% -0% NS 
alprazolam 2.23 0.78 5% NS -14% -11% -37% 
methadone 4.14 0.75 -10% NS -51% -45% -13% 
diazepam 2.63 0.58 15% NS -4% NS 17% -6% NS 
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 Both the Vivid GR and the NoviPlex membranes caused a measurable decrease in the 
concentration for all five drugs while the CytoSep membrane showed a noticeable decrease for 
three drugs, but not for atenolol and carbamazepine.  The presumed cause of the decrease in drug 
concentration in membrane fractionated plasma is that the drug is binding to the membrane.  It has 
been shown in several studies that polysulfone based membranes, like the Vivid GR, cause a 
decrease in drug concentration in blood21,22.  This means that membranes like the Vivid GR will 
be poor choices for obtaining plasma for therapeutic drug monitoring purposes. 
2.5.3 Membrane Treatment to Improve Plasma Separation 
 The CytoSep membrane showed the lowest amount of drug binding, but also resulted in 
the highest level of red blood cell content in the collected plasma sample.  Methods were 
investigated for improving the plasma fractionation efficiency from this membrane.  Previous work 
showed that causing cells to agglutinate allowed for plasma to be separated from blood cells in 
paper based devices23.  This work employed anti-A and anti-B antibodies and thus would not cause 
type O blood (which lack these antigens) to agglutinate23.  The alternative options of fibrinogen, a 
key protein in the coagulation cascade24, and alum25 were used instead.  Fibrinogen and alum were 
spotted directly onto the membranes and allowed to dry before assembly of the insert. 
 Fibrinogen concentrations ranging from 20 µg/mL to 1000 µg/mL were tested and 
concentrations of 75 µg/mL or greater showed measurable drug binding for the initial test set of 
drugs.  However, concentrations less than 50 µg/mL showed minimal improvement in cell 
lysis/penetration. The 50 µg/mL fibrinogen treated membranes showed cell lysis/penetration of 
approximately 3% compared to approximately 6% for the untreated membrane.  This was an 
improvement to the plasma separation efficiency, so the treated membrane was selected for further 
testing. 
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 Similarly, different concentrations of alum were evaluated for their improvements to 
separation efficiency.  However, it was found that the amount of alum required to improve the 
plasma separation also yielded irreproducible amounts of plasma on the collection disc.  A lower 
concentration (40 µg/mL instead of 60 µg/mL) of alum was chosen for further testing even though 
the separation efficiency was similar to that of the untreated membrane.  This testing was 
performed to evaluate if a non-protein agglutination agent would have a noticeable impact on the 
binding properties of the drugs. 
2.5.4 Evaluation of Errors from Drug Binding and Cell Lysis 
 A selection of drugs with varying logP and KB/P (a measurement of the distribution between 
red blood cells and plasma) values were tested to better understand the binding characteristics of 
the treated and untreated CytoSep membrane as well as the errors caused by blood cell lysis.  
Plasma samples were tested along with blood to determine if plasma samples could be used to 
evaluate membrane drug binding without the complicating effects of red blood cell 
lysis/penetration (Table 2.5). 
 None of the nine drugs tested showed significant binding to the membrane from plasma 
samples.  When whole blood was applied to the membrane rather than plasma, six of the drugs 
showed a measurable decrease in analyte concentration.  If cell lysis/penetration was the principal 
source of error in blood, then the error after passing through the membrane should be negative for 
drugs with a KB/P < 1 (drug is more concentrated in plasma so lysing cells would dilute the plasma 
concentration), positive for drugs with a KB/P > 1 (drug more concentrated in the red blood cells so 
lysing cells increases plasma concentration), and minimal for drugs with a KB/P  close to 1 (drug 
evenly distributed between cells and plasma).  The change in drug amount in the collection disc 
did not correlate with the KB/P.  For example, selegiline and chlorpheniramine have a KB/P above 
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1, but showed a significant decrease in concentration after passing through the membrane.  
Methadone had a negative error, but it was much greater in magnitude than would be expected 
based off the measured levels of cell lysis/penetration and its KB/P.  This error is likely caused by 
higher levels of drug binding to the membrane in blood samples compared to plasma.  One possible 
reason for the higher levels of membrane drug binding in blood samples compared to plasma 
samples is the slower passage of blood samples through the membrane.  Plasma samples pass 
through the membrane considerably faster due to lower viscosity and because the membrane is not 
clogged by blood cells.  The decreased extraction time (roughly 5 times less than whole blood) 
could lead to less apparent binding due to the shorter interaction time with the membrane.  This 
indicates that plasma is not a suitable matrix for evaluating drug binding by the fractionation 
membranes. 
 Table 2.5 also shows the logP (octanol-water partitioning) for each analyte.  All of the 
drugs with a logP of 3 or greater exhibited negative deviations of 20% or more against the untreated 
membrane in whole blood samples. All the drugs with a logP below 3, on the other hand, deviated 
by 15% or less.  This suggests that drugs with a KB/P close to 1 and a logP below 3 are the least 
likely to be biased by membrane fractionation.   
 Plasma drug concentrations obtained using the membranes treated with agglutination 
agents were also evaluated.  Although fibrinogen significantly decreased the amount of cell 
lysis/penetration, it did not improve the analyte error.  For the alum treated membranes, the amount 
of cell lysis/penetration was not significantly different than the untreated membrane for most 
analytes.  This suggests that while agglutinating agents may reduce cell lysis, the amount of error 
from membrane interactions has a more significant impact. 
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2.5.5 Quantitative Analysis by Paper Spray MS/MS 
 We built a prototype paper spray cartridge incorporating a plasma fractionation membrane 
(Figure 2.2).  A drop of blood applied to the cartridge yields a plasma spot that can be analyzed 
directly from the cartridge via paper spray MS without any additional sample preparation.  To 
evaluate the ability of the method to quantify plasma concentrations, blood samples were prepared 
with concentrations of 0.3 and 1.5 µg/mL. The plasma was then fractionated using the fibrinogen 
treated membrane inserts and compared to centrifuged plasma from the same blood sample using 
calibration curves (Figure 2.3).  The results for the calibration lines and differences between the 
membrane fractionated plasma samples and centrifuged plasma control samples are shown in table 
2.6.  Concentration data for both the paper spray MS and HPLC-MS results can be found in table 
2.7.  While the slopes of the lines for HPLC-MS experiment were different than paper spray-MS, 
likely due to the difference in how the samples were prepared, the atenolol and carbamazepine 
concentrations and detection limits were similar for both the membrane fractionated plasma and 
centrifuged plasma using both methods.  However, the paper spray results were obtained without 
an extraction step (30-35 minutes) or a HPLC run (around 14 minutes per sample).  This 
significantly reduced the amount of time and effort required to obtain the result.  
   
48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Paper Spray MS Calibration Curve for Carbamazepine. Calibration curve for 
carbamazepine in plasma obtained by paper spray mass spectrometry.  
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Table 2.6: Comparing Centrifuged Plasma and Membrane Fractionated Plasma Using HPLC and 
Paper Spray.  HPLC-MS and paper spray MS results for the calibration curves and the deviation 
between plasma obtained by centrifugation to the plasma fractionated using a fibrinogen treated 
membrane.  NS indicates that the difference between the results for the control and experimental 
were not statistically significant (p>0.05). 
 
 
 
 
 
Table 2.7: Comparing Drug Concentrations in Centrifuged Plasma and Membrane Fractionated 
Plasma Using HPLC and Paper.  Spray Average plasma concentrations with standard deviation 
using HPLC-MS and paper spray MS. 
 
 
  
Drug Method Slope Intercept r2 
LOD 
µg/mL 
% deviation, 
0.3 µg/mL 
% deviation, 
1.5 µg/mL 
Atenolol 
HPLC 
0.405 0.002 0.982 0.03 -2% NS -0.4% NS 
Carbamazepine 4.18 0.1 0.983 0.04 10% NS -9% NS 
Atenolol paper 
spray 
0.185 0.0007 0.995 0.02 -9% NS -8% NS 
Carbamazepine 6.24 0.01 0.989 0.03 -4% NS -10% NS 
Drug Method 
Cytosep 
0.3 µg/mL 
Cytosep 
1.5 µg/mL 
Centrifuge 
0.3 µg/mL 
Centrifuge 
1.5 µg/mL 
Atenolol 
HPLC 
0.32±0.06 1.7±0.2 0.33±0.03 1.7±0.2 
Carbamazepine 0.26±0.06 1.4±0.2 0.29±0.03 1.5±0.2 
Atenolol paper 
spray 
0.24±0.02 1.6±0.3 0.22±0.02 1.7±0.1 
Carbamazepine 0.23±0.02 1.5±0.3 0.24±0.03 1.6±0.3 
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2.6 Conclusion 
 In conclusion, 3 different membranes were evaluated for lysis and drug binding.  These 
membranes were made from a variety of materials ranging from polymers to natural and synthetic 
fibers.  Two of the three membranes, the Vivid GR polysulfone membrane and the NoviPlex 
plasma extraction card, exhibited noticeable amounts of drug binding for each of the five drugs 
tested.  The third membrane, the CytoSep membrane, exhibited no significant binding for atenolol 
and carbamazepine.  While the CytoSep membrane had the most favorable drug binding 
characteristics, it showed the poorest fractionation efficiency as measured by the red blood cell 
content in the fractionated plasma. Overall, this membrane could be used for quantitative analysis 
for drugs with a logP less than three and a KB/P near unity, but is not a universal solution. 
 A proof-of-concept design for a simple paper spray cartridge for performing direct plasma 
analysis from a drop of blood was built and tested.  The results were found to be comparable to 
extraction followed by HPLC-MS/MS.  Unbiased results are only obtainable for atenolol and 
carbamazepine, however, due to drug binding and cell lysis. Further investigations are required to 
identify membrane materials that are capable of maintaining good plasma fractionation efficiency 
but without nonspecific drug binding.   
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 THE IMPACTS OF PAPER PROPERTIES ON MATRIX 
EFFECTS DURING PAPER SPRAY MASS SPECTROMETRY 
ANALYSIS OF COMMON AND EMERGING DRUGS OF ABUSE 
3.1 Abstract 
 Designer drugs, drugs synthesized in a lab that mimic other drugs of abuse, have become 
a major cause of death in the United States.  Limitations in either speed, sensitivity or selectivity 
of current analytical techniques hinders rapid detection.  Paper spray mass spectrometry (MS) is a 
rapid ambient pressure technique capable of detecting analytes in complex matrices.  However, 
due to a lack of sample cleanup and chromatography, matrix effects can have a significant impact 
on the detection limits.  Previous work has shown that the paper used has an impact on matrix 
effects, but the current literature lacks a systematic approach to studying different properties of 
paper with regards to matrix effects.  In this work, the effect of pore size, flow rate, and thickness 
on ionization efficiency and recovery was assessed.  Cellulose thin layer chromatography (TLC) 
plates were made along with a universal spray cartridge to provide a porous spray substrate similar 
to paper but with easily changed thickness.  It was found that substrates with the highest filtration 
properties (thicker, slower flow rate, or smaller pore sizes) had lower analyte recovery but 
improved ionization efficiency.  This was verified with an offline extraction conducted with a 3D 
printed centrifuge extractor.  Paper/solvent combinations were tested with urine samples to 
determine if selecting a paper and solvent with better ionization efficiency could improve detection 
limits.  While minimizing ionization suppression improved detection limits for some drugs, those 
charged at physiological pH were largely unaffected.  For analytes that showed improvement, both 
the paper and the solvent had an impact; but, solvent had the larger impact. 
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3.2 Introduction 
In recent years, designer drugs (drugs produced in a lab to mimic the effects of other drugs of 
abuse) have become more prevalent1-3.  Manufacturers take advantage of these drugs’ unique 
structures to avoid detection and regulation1.  Synthetic cannabinoids, for example, are sprayed on 
dried plant matter and often marketed as herbal incense while being marked as “not for human 
consumption”4.  However, the active ingredient may be one or more of any molecule from a library 
of compounds developed for research purposes4-5.  This can have disastrous consequences as the 
dosage is poorly controlled, and the potency of any individual compound can vary wildly2, 5.  As 
a result, consumers can experience side effects and can end up overdosing2, 4.  Another alarming 
trend is that fentanyl and its derivatives are being found with increasing regularity as both 
adulterants in heroin and as drugs of abuse by themselves2-3.  Coupled with a highly variable range 
in potency of fentanyl analogues (ranging from less potent to one hundred times more potent than 
fentanyl6) has contributed to a spike in overdose fatalities2-3, 6.  Due in part to these emerging drug 
trends the number one cause of injury death in the united states has become drug poisoning (ahead 
of suicide, motor vehicle crashes, and firearms)2. 
With the rise in number and potency of illicit drugs comes a need for rapid, selective and 
sensitive analytical techniques.  A quick screening method for samples could give law enforcement 
an early warning about what type of drug is showing up locally and help emergency rooms be 
prepared for further overdose cases.  The most common methods used for drug screening are often 
either immunoassays (IAs) or mass spectrometry (MS) paired with gas chromatography (GC) or 
high performance liquid chromatography (HPLC)7-10.  While IAs are simple and fast, they have 
problems with sensitivity and selectivity making them poorly suited for the current crisis11.  GC-
MS and LC-MS have better selectivity and sensitivity, but require sample preparation and the 
chromatography step adds analysis time to each sample.  Ideally a screening technique would be 
55 
 
 
simple and direct with minimal required training and fast analysis times making paper spray MS a 
viable option. 
 Many designer drugs require low detection limits due to their high potency.  A limitation 
to detection limits for paper spray-MS is the presence of matrix effects.  Without a separation or 
sample cleanup step the detection limits can be increased by poor analyte recovery and ion 
suppression12.  Recent work on improving detection limits has involved integrating a solid phase 
extraction step with a paper spray cartridge13, performing a solvent extraction from the sample on 
top of hydrophobic paper14, and utilizing a membrane to filter out the red blood cell component of 
blood15.  An alternate approach involves changing the porous spray substrate to optimize detection 
limits.  Studies have included paper treated with various coatings (such as silica or zirconia)16-19, 
comparing different types of paper20-21 and non-paper porous spray substrates22-27.  These studies 
give insight on the role the porous substrate takes in paper spray-MS.  However, few studies of the 
spray substrate take a systematic approach to try to elucidate what specific properties of the paper 
have what impacts on the matrix effects.  Previous work has shown that by increasing the distance 
between the sample and spray tip lowers the impact of ion suppression while hurting recovery28.  
This suggests that the paper itself could play a role in mitigating matrix effects. 
 Here we describe a systematic approach to comparing spray substrates to better determine 
what properties of the paper impact ionization efficiency and recovery.  Initially a subset of drugs 
was selected that included drugs with varying physical properties as well as fentanyl and synthetic 
cannabinoids.  To study a single property, such as thickness or pore size, papers were selected with 
as many similar properties as possible with one property significantly different.  Cellulose based 
thin layer chromatography (TLC) plates were made to provide a cellulose based substrate with 
easily controllable dimensions.  To accommodate the wide variety of spray substrates and 
56 
 
 
minimize any differences in experimental procedure a universal paper spray cartridge capable of 
housing any type of porous spray substrate was fabricated using a combination of 3D printing and 
a bench top milling machine.  The ionization efficiency results were further tested using a 3D 
printed modification to a centrifuge tube that allowed for solvent to be pulled through a dried 
biofluid and spray substrate and subsequently analyzed by syringe elution using ESI-MS. 
3.3 Materials 
 All the pharmaceuticals and their stable isotopic labels (SIL), except atenolol D7, were 
obtained from Cerilliant (Round Rock, TX, U.S.A.).  Atenolol D7 was obtained from CDN 
isotopes (Pointe-Claire, QC, Canada) as a powder (≥98% purity).  AB-CHMINACA and AM-
2201 and there SIL’s were obtained from Cayman Chemical (Ann Arbor, Michigan, U.S.A).  
HPLC grade methanol, acetonitrile, formic acid and acetic acid came from Fisher Scientific 
(Waltham, MA, U.S.A).  Blood and urine were obtained from a single volunteer.  The papers tested 
included Whatman grade 31 ET and 3MM chromatography paper and grade 4 and 5 filter paper 
from GE Healthcare Life Sciences (Pittsburgh, PA, U.S.A.).  Cellulose powder (20 µm and 50 µm 
particle size) and starch (from rice) were obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.).  
The clamp to hold the universal cartridge together was 3D printed in VeroBlue photopolymer using 
an Objet 30 pro from Stratasys (Eden Prairie, MN, U.S.A).  The universal cartridge and the base 
of the TLC plates were Delrin plastic from McMaster-Carr (Elmuhurst, IL, U.S.A.).  The cartridge 
was manufactured using a bench-top mini milling machine from Sherline (Vista, CA, U.S.A.).  
The centrifuge modification was 3D printed using a polypropylene filament using an Ultimaker 
2+ extended (Geldermalsen, Gelderland, Netherlands).  The TLC plates were cut using a Speedy 
300 laser engraver from Trotec (Wels, Austria). 
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3.4 Methods 
3.4.1 Paper Selection 
 Papers were selected in pairs with the criteria that most physical properties were as similar 
as possible and one property was significantly different. Ultimately two pairs of paper were 
selected based on their different pore sizes (filter paper) and flow rates (chromatography paper) 
given on the manufacturer website (Table 3.1).   
The flow rate during paper spray was determined experimentally using a glass capillary with 1 µL 
gradients marked on the side.  The capillary was placed nearly horizontal against the back edge of 
the paper and the rate of solvent consumption was measured using a stopwatch to time how long 
it took for 15 µL of solvent to be consumed.  The flow rate due to paper spray was determined by 
finding the difference between the average rate of solvent consumption for three runs without 
voltage (evaporation only) and with voltage (paper spray and evaporation). 
3.4.2 Analyte Selection 
 To better understand if and how the different physical properties of small molecules 
interact with the selected paper properties a selection of seven pharmaceuticals were selected in 
addition to two synthetic cannabinoids and fentanyl (Table 3.2).  In order to study the wide 
variability of analyte physical properties that can be encountered, analytes were selected from 
pharmaceuticals with documented properties to include a wide range of logP, pKa (acid and base), 
and physiological charge values.  The remaining three analytes were included as targets of specific 
interest for the current crisis. 
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Table 3.1: Properties of Whatman Paper.  Physical properties of chromatography and filter paper.  
(*) Indicates properties not listed on the manufacturer website that were measured using a caliper 
and scale. 
 
 
 
 
 
 Table 3.2: Drug Properties.  Physical properties of the pharmaceuticals from drugbank. 
 
  
Paper 
Pore Size 
(µm) 
Thickness 
(µm) 
Weight 
(g/m2) 
Flow Rate 
(mm/30 min.) 
Whatman Grade 4 Filter 25 210 92 - 
Whatman Grade 5 Filter 2.5 200 100 - 
Grade 3MM Chromatography - 340 186* 130 
Grade 31 ET Chromatography - 500 183* 225 
Analyte 
Molecular 
Weight 
logP 
pKa 
(acid) 
pKa 
(base) 
Physiological 
Charge 
Alprazolam 308.77 2.23 18.3 5.08 0 
Atenolol 266.336 0.57 14.08 9.67 1 
Carbamazepine 236.269 2.1 15.96 -3.8 0 
Diazepam 284.7 2.63 NA 2.92 0 
Fentanyl 336.471 4.12 NA 8.77 1 
Gabapentin 171.237 -1.9 4.63 9.1 0 
Hydrocodone 299.368 2.13 18 8.61 1 
Phenylephrine 167.205 -0.69 9.07 9.69 1 
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3.4.3 TLC Plate Fabrication 
 Ideally, spray substrates could be fabricated with controllable properties for targeted 
studies of how different physical aspects of the spray substrate impact the overall analysis.  The 
problem is that paper manufacture is a complex process with many subtle aspects involved in 
producing a uniform and reproducible product.  A simpler alternative is to manufacture TLC plates 
using cellulose powder as simulacrum of paper.  TLC plates can be manufactured from a wide 
variety of stationary phases and binders29.  Black Delrin plastic cut into two-inch squares was used 
as a backing for the plates.  Because 0.3 mm Delrin plastic is sold in rolls instead of flat sheets it 
was baked under a brick of aluminum at approximately 150°C for four hours to flatten the squares 
and cooled under the brick until room temperature.  The surface was scored with sand paper prior 
to baking and washed prior to addition of the stationary phase.  Starch was used as a binder at three 
percent by mass to improve ruggedness of the plate.  A slurry was prepared by mixing the 
cellulose-starch mixture in a 1:3 ratio with boiling water to make a thicker stationary phase or 1:6 
with boiling water to make a thinner stationary phase.  One aliquot of 3 mL of the slurry was 
spread evenly on the scored surface of the Delrin plastic square.  The plates were dried on the 
benchtop at room temperature.  The plates were cut with the stationary phase face down into 
uniform shapes (Figure 3.1) using a Speedy 300 Trotec laser engraver at approximately eighteen 
percent power.  Thick stationary phase TLC plates had 770±90 µm of cellulose powder adhered 
while thin stationary phase TLC plates had 140±10 µm. 
3.4.4 Universal Spray Cartridge 
 To minimize the differences between how the spray substrates were analyzed, a spray 
cartridge was designed that could accommodate substrates of vastly different thickness and 
fragility.  The cartridge consists of three parts (Figure 3.2). The first part of the cartridge, milled 
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out of delrin plastic, consisted of a top and bottom that fit together to hold the spray substrate.  The 
top portion had a hole to contain a 3-millimeter sample punch directly on top of the spray substrate 
with a larger hole above it to serve as a solvent reservoir.  A small hole behind the solvent well 
contained a wire that contacted the spray substrate and allowed the application of voltage.  The 
second part, 3D printed out of photopolymer, was a clamp that fit around the substrate holder with 
a nut and bolt to tighten the two pieces together.  
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Figure 3.1: TLC Spray Substrates.  Cut TLC spray substrates with a thick (left) and thin (right) 
stationary phase. 
 
 
 
Figure 3.2: Universal Spray Cartridge.  Delrin substrate holder with solvent well and conductive 
wire (left), 3D printed clamp to hold parts together (middle), and cartridge containing thick TLC 
spray substrate on right.  
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3.4.5 Analytical Run 
 Analysis was carried out on a Thermo Fisher Scientific Q Exactive Focus Orbitrap mass 
spectrometer in parallel reaction monitoring mode (PRM).  Measurements were made of the most 
intense fragment of the [M+H]+ precursor for each analyte.  An analytical run consisted of two 
minutes of 4.5 kV applied voltage with six seconds of 0 V at the beginning and end of the analytical 
run.  Samples consisted of 2.5 µL of either blood or methanol containing 2.5 µg/mL of each analyte 
spotted on a 3 millimeter punch of 31 ET chromatography paper.  Samples were dried at room 
temperature on the benchtop.  The spray solvent was spiked with 250 ng/mL of stable isotopic 
labels (SIL) of the ten analytes.  The spray solvent consisted of either 95:5 methanol:water with 
100 ppm acetic acid for filter paper or 90:10 acetonitrile:water with 100 ppm formic acid for the 
TLC plates and chromatography paper.  When comparing solvents to optimize detection limits, 
both solvents used formic acid. 
3.4.6 Comparing Recovery and Ionization Efficiency 
 Recovery was measured as a ratio between the area under the curve (AUC) for the analyte, 
which should decrease with poorer recovery, divided by the AUC for the SIL in the spray solvent 
which should be unaffected by recovery.  Relative recovery is the ratio of the recovery from a 
biofluid and the recovery from neat as shown in equation 1. 
1. 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 =  
(
𝐴𝑈𝐶𝐴𝑛𝑎𝑙𝑦𝑡𝑒 𝑓𝑟𝑜𝑚 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑈𝐶𝑆𝐼𝐿 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡
)
𝑏𝑖𝑜𝑓𝑙𝑢𝑖𝑑
(
𝐴𝑈𝐶𝐴𝑛𝑎𝑙𝑦𝑡𝑒 𝑓𝑟𝑜𝑚 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑈𝐶𝑆𝐼𝐿 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡
)
𝑛𝑒𝑎𝑡
 
 
The signal of the SIL contained in the spray solvent should primarily be decreased by the matrix 
components coeluting from the sample so measuring the ratio of the SIL using a biofluid sample 
and a matrix free sample measures the relative ionization efficiency as shown in equation 2. 
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2. 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =  
(𝐴𝑈𝐶𝑆𝐼𝐿 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡)𝑏𝑖𝑜𝑓𝑙𝑢𝑖𝑑
(𝐴𝑈𝐶𝑆𝐼𝐿 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡)𝑛𝑒𝑎𝑡
 
When comparing similar spray substrates (i.e. comparing two kinds of filter paper or two 
thicknesses of TLC plate) the change in relative recovery or relative ionization efficiency was 
calculated as an absolute difference of the two percentages. The results for each pair of spray 
substrates were evaluated for statistical significance (p<0.05) using a student T test (n=5 for each 
spray substrate).   
3.4.7 Sample Extractor 
 There is an inherent amount of imprecision when the SIL is dissolved in the spray solvent 
due to the variability in the absolute signal (30% relative standard deviation is common).  This 
makes it difficult to confirm trends in the ionization efficiency which is based solely on the 
absolute signal as shown in equation 2.  To verify the trends observed with paper spray-MS using 
a secondary method an extractor was designed to pull solvent through the spray substrates so that 
it could be sprayed using a syringe pump and electrospray ionization (ESI) spray source.  The 
extractor was 3D printed in polypropylene plastic, to be solvent resistant, and designed to be 
inserted into a 2 mL centrifuge tube using the cap to seal the extractor (Figure 3.3).  
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Figure 3.3: Centrifuge Extractor.  A: diagram of extractor, B: individual components of 
extractor, C: top down view, D: assembled extractor. 
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Changes in ionization efficiency were measured by comparing the absolute signal of the SIL 
spiked into a urine extract, solvent that had been passed through dried urine samples, and the SIL 
spiked into the same urine extract after it had been passed through the different papers.  The urine 
extract was generated by stacking three 3 mm punches of 31ET paper with dried urine in the 
extractor and adding spray solvent before it was centrifuged at 2500 RPM for 10 minutes.  Three 
extracts were pooled then processed a second time through the four different papers to assess the 
ability of different papers to remove matrix components.  Within the extractor a strip of paper was 
fed through a square slot and bent over in the bottom of a 3 mm diameter well.  On top of the paper 
multiple punches of the same paper were inserted to hold the paper strip in place and prevent leaks.  
Six punches had to be used for the filter papers while four and three punches were used for 3MM 
and 31ET respectively to account for the differences in paper thickness.  Three replicate extractions 
were tested for each paper and compared with three extracts that hadn’t been passed through 
additional paper.  The resulting solutions were spiked with 250 ng/mL of the ten drug’s SIL and 
analyzed by syringe pump infusion to the Thermo H-ESI source at 4.5 kV, a sheath gas flow rate 
of 15, an auxiliary gas flow of 5 arbitrary units, and flow rate of 10 µL per minute.   
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The percent signal increase was calculated using equation 3 where AUCSIL Paper Extracted is the area 
under the curve for the SIL spiked into urine extract that had been passed through additional paper 
and AUCSIL Urine Extract is the area under the curve for the SIL spiked into urine extract that hadn’t 
been passed through any additional paper.  Papers were compared by finding the absolute 
difference between the percent signal increase. 
3. 𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑆𝑖𝑔𝑛𝑎𝑙 𝐼𝑛𝑐𝑟𝑒𝑎𝑠𝑒 = (
𝐴𝑈𝐶𝑆𝐼𝐿 𝑃𝑎𝑝𝑒𝑟 𝐸𝑥𝑡𝑟𝑎𝑐𝑡𝑒𝑑
𝐴𝑈𝐶𝑆𝐼𝐿 𝑈𝑟𝑖𝑛𝑒 𝐸𝑥𝑡𝑟𝑎𝑐𝑡
− 1) ∗ 100% 
3.4.8 Optimizing Detection Limits 
 To determine the impact of paper properties on detection limits, calibration curves were 
generated using combinations of two spray solvents, methanol and acetonitrile, and the two most 
drastically different papers, grade 4 filter paper (which is thin with large pores) and 3MM 
chromatography paper (which is thicker with a slower flow rate).  Urine was selected as a biofluid 
due to past work showing that it often has poor ionization efficiency with minimal problems with 
recovery28.  To ensure that analyte binding to a plastic cartridge did not influence results at low 
concentrations, a positioning device that only contacted the spray substrate via an alligator clip 
was 3D printed. A pipette tip in contact with the paper acted as a solvent reservoir (Figure 3.4).    
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Figure 3.4: Minimal Contact Cartridge.  3D printed cartridge to minimize contact between the 
paper and the cartridge.  
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Calibrators were prepared at 5, 10, 50, 100, 500, and 1000 ng/mL in urine.  The SIL internal 
standard was spiked into each sample at 50 ng/mL.  Two replicates were run at each concentration 
with data points yielding no signal being omitted.  Slope and Y-intercept were determined by linear 
regression30 with a weighting factor of 1/X2.  Detection limits were calculated by three times the 
standard error of the Y-intercept divided by the slope.  Changes in absolute signal intensity were 
calculated by averaging the signal for the SIL for ten runs and finding the factor by which the 
signal increased when changing grade 4 filter paper to 3MM paper without changing the solvent 
(acetonitrile), changing from methanol to acetonitrile solvent without changing the paper (3MM) 
and changing from conditions for higher theoretical recovery (grade 4 filter paper with methanol) 
to higher theoretical ionization efficiency (3MM with acetonitrile solvent). 
3.5 Results and Discussion 
3.5.1 Flow Rate During Paper Spray 
 The average flow rate of solvent due to paper spray (Table 3.3) was calculated in µL/minute 
by finding the difference between the rate of solvent consumption without voltage and the rate of 
solvent consumption during paper spray.  It was found that when comparing filter papers or 
chromatography papers, a smaller pore size or slower chromatographic flow rate corresponds to a 
slower flow rate during paper spray mass spectrometry.  The flow rate also seemed to be similar 
between the two solvents tested. 
3.5.2 Comparing relative Ionization Efficiency and Relative Recovery 
Relative ionization efficiency and relative recovery were determined for each pair of papers and 
the differences evaluated using a T test (p≤0.05) to determine if the results were statistically 
different.  An absolute difference was calculated for papers that had statistically different results 
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for the majority of the analytes.  A consistent trend emerged when comparing grade 4 to grade 5 
filter paper, 31ET to 3MM chromatography paper, thin stationary phase TLC plates to thick 
stationary phase TLC plates: an increase in the relative ionization efficiency (Figure 3.5) 
accompanies a decrease in the relative recovery (Figure 3.6). 
70 
 
 
 
Figure 3.5: Changes in Ionization Efficiency.  The absolute change in relative ionization 
efficiency when comparing increased substrate thickness (thin cellulose powder TLC plate to 
thick TLC plate), decreased flow rate (grade 31 ET chromatography paper to 3MM 
chromatography paper), and decreased pore size (grade 4 filter paper to grade 5 filter paper).  
Bars showing a change in ionization efficiency over 100% are due to higher relative standard 
deviation from the SIL being in the spray solvent.  
  
Figure 3.6: Changes in Recovery.  The absolute change in relative recovery when comparing 
increased substrate thickness (thin cellulose powder TLC plate to thick TLC plate), decreased 
flow rate (grade 31 ET chromatography paper to 3MM chromatography paper), and decreased 
pore size (grade 4 filter paper to grade 5 filter paper).  
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The common factor for the trends shown in figures 3.5 and 3.6 is that the decrease in recovery and 
increase in ionization efficiency correlates with the filtration effectiveness of the papers.  This is 
shown with the decreasing pore size (the filter paper), decreasing flow rate (chromatography paper) 
and with substrate thickness (the TLC plates).  In table 3.3 it was shown that smaller pore size also 
led to a decrease in flow rate so it could also be a factor of rate of flow through the paper.  Another 
factor is that smaller pore size and increased thickness increases the interaction surface area 
between the paper fibers and the solvent, which in turn allows greater interaction of the analyte 
and matrix components with the cellulose.  This result is similar to previous work where an 
extended path length originally showed this tradeoff between decreased recovery and improved 
ion suppression28.  This means that properties of the spray substrate that improve the spray 
substrates ability to act as a filter, including longer path length, thicker paper, slower flow rate or 
smaller pore size, will decrease recovery while improving ionization efficiency.  
3.5.3 Using Centrifuge Extractor to Determine Ionization Efficiency 
 To verify trends in ionization efficiency (Figure 3.5) a centrifuge was used to pull spray 
solvent with matrix components through different papers.  The solvent was then pooled and 
sprayed using a syringe pump and ESI source to measure signal change.  The percent signal 
increase was calculated for each paper using equation 3; the effect of decreasing pore size 
(comparing grade 4 filter paper to grade 5 filter paper), decreasing flow rate (comparing 31ET 
chromatography paper to 3MM chromatography paper), and the two most significantly different 
papers (3MM chromatography paper and grade 4 filter paper) are reported in figure 3.7.  
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Figure 3.7: Comparing Signal Increases from Extracting Through Different Papers.  The change 
in percent signal increase for the SIL spiked in urine extract when compared to the same urine 
extract that was passed through various papers.  The papers compared have decreasing pore size 
(comparing grade 4 filter paper to grade 5 filter paper) and decreasing flow rate (comparing 
31ET chromatography paper to 3MM chromatography paper). 
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Looking at the results in figure 3.7, several of the trends pointed out earlier repeated.  Alprazolam, 
carbamazepine, diazepam, AM-2201 and AB-CHMINACA showed a consistently higher signal 
with the slower flow rate 3MM being better than 31ET.  The differences also showed up between 
grades 5 and 4 filter paper, but were less extreme.  This could have been due to the thinness of the 
filter paper offsetting the change in pore size.  Comparing two dramatically different papers, 3MM 
which is thick with a slow flow rate and grade 4 filter paper which is thin with a large pore size, 
the changes in ionization efficiency were more pronounced.  Other trends emerged that were not 
obvious with the less precise paper spray measurements.  Atenolol, fentanyl, gabapentin, 
hydrocodone and phenylephrine all showed minimal improvement compared to the other analytes 
tested.  Looking at the properties of these analytes in table 3.2, most of these analytes are charged 
at physiological pH except for gabapentin which is zwitterionic.  A few outliers exhibited trends 
opposite to expected behavior (specifically a decrease in ionization efficiency for carbamazepine, 
gabapentin and AM-2201 with decreasing pore size and atenolol with decreasing flow rate).  These 
outliers are most likely due to higher imprecision from working with thinner paper or an analyte 
that shows minimal improvement from having the matrix cleaned up using paper (in the case of 
atenolol). 
3.5.4 Optimizing Detection Limits 
 The trends discussed above showed a consistent tradeoff between ionization efficiency and 
recovery.  This was also found in the two solvent systems investigated, with acetonitrile showing 
higher ionization efficiency and methanol showing better recovery (data not shown).  This makes 
predicting an ideal combination of substrate and solvent to improve detection limits difficult.  In 
theory, if the primary limitation to detection limits for a biofluid is one matrix effect and not the 
other it should just be a matter of selecting a solvent and paper to minimize one matrix effect.  For 
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example, urine has been shown to have minimal problems with recovery and is an ideal choice for 
determining if selecting the paper and solvent to maximize ionization efficiency improves the 
detection limits to a significant extent.  Four combinations of solvent and paper (the two solvents 
acetonitrile and methanol with the two papers grade 4 filter paper and 3MM chromatography paper) 
were evaluated for their detection limits based on estimates from a calibration curve (Table 3.4).   
  
75 
 
 
 
 
 
Table 3.3: Paper Spray Flow Rates.  Flow rates ± the standard deviation (N=3) for each of the 
commercially available papers with each solvent in µL/minute. 
 
 
 
 
 
 
 
 
Table 3.4: Detection Limits Using Two Different Papers and Two Different Solvents.  Detection 
limits estimated from calibration curves in urine using four different combinations of paper and 
solvent.  The solvents contained 10% and 5% water for acetonitrile and methanol respectively.  
*The SIL for phenylephrine was a non-detect for these runs and is omitted. 
 
  
 
90:10 
acetonitrile:water 
95:5 
methanol:water 
31ET 5.8±0.5 5±1 
3MM 2.4±0.2 2.5±0.3 
filter 4 3.1±0.2 2.5±0.3 
filter 5 1.1±0.1 1.0±0.3 
  3MM Filter 4 
Drug acetonitrile MeOH acetonitrile MeOH 
AB-CHMINACA 0.94 7.6 1.7 37 
Alprazolam 0.66 5.3 1.2 3.8 
AM-2201 1.4 3.1 1.5 1.9 
Atenolol 2.3 2.5 1.5 2.8 
Carbamazepine 1.0 1.7 1.0 2.2 
Diazepam 1.8 2.0 2.5 4.9 
Fentanyl 0.86 1.2 1.1 1.0 
Gabapentin 11 11 9.4 15 
Hydrocodone 2.6 8.6 2.7 2.5 
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If optimizing the solvent and paper combination for ionization efficiency was all that was required 
to lower detection limits in urine, then the combination of 3MM chromatography paper and 
acetonitrile would have given the lowest detection limits.  For several analytes this is true, but the 
difference is minimal when comparing 3MM and grade 4 filter paper both using an acetonitrile 
solvent.  To get an idea of the absolute change in signal for the SIL the change in signal intensity 
was calculated (Figure 3.8) when comparing different papers with the same solvent (acetonitrile), 
different solvents but the same paper (3MM) and when changing both as a factor difference.    
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Figure 3.8: Increases in Signal from Changing Paper or Solvent.  The factor changes in absolute 
SIL signal when changing the paper (grade 4 filter paper to 3MM), when changing the solvent 
(methanol to acetonitrile) and when changing both.  *The SIL for phenylephrine was a non-
detect for these runs. 
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As shown in figure 3.8 increases in absolute signal were greater when changing the solvent than 
the paper, but the increase was greatest when both were changed.  Looking at the data in terms of 
the properties of the analytes from table 3.2 the analytes charged at physiological pH (atenolol, 
fentanyl and hydrocodone) all showed increases in signal under a factor of five.  This suggests that 
analytes that tend to have lower overall ionization efficiencies, namely those that aren’t charged 
at physiological pH, are more likely to show more significant changes in absolute signal when 
using papers that act as a more efficient filter (like 3MM paper) and acetonitrile for the spray 
solvent.  This is reflected in table 3.4 in that atenolol and fentanyl (both of which are charged at 
physiological pH) had very similar detection limits for all four combinations while alprazolam and 
AB-CHMINACA showed a noticeably lower detection limit for 3MM paired with acetonitrile.  
However, this did not hold true for every analyte and in many cases the improvements in detection 
limits were minimal.  With detection limits being a factor of both ionization efficiency and 
recovery and with each analyte behaving differently it is difficult to predict whether optimizing 
for one matrix effect will drastically improve detection limits.  In general, it has been shown here 
that using a paper that acts as a more effective filter in combination with a solvent with better 
ionization efficiency such as acetonitrile improved absolute signal intensity and sometimes the 
detection limits for uncharged analytes. 
3.6 Conclusion 
 In conclusion, a systematic approach was used to evaluate the impact of specific paper 
properties on matrix effects during paper spray-MS.  Two pairs of paper were selected with similar 
properties except for one property being significantly different.  Cellulose TLC plates were 
manufactured to test the impact of thickness.  A selection of ten analytes were used to gauge the 
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differences associated with differing physical properties.  An offline extractor was 3D printed to 
allow for the study of paper properties without using paper spray. 
It was found that there is a consistent tradeoff between ionization efficiency and recovery 
with spray substrates that act as a more efficient filter due to smaller pore size, slower flow rate or 
thicker spray substrate lowering recovery while improving ionization efficiency.  Experiments 
using an offline extractor verify the trends associated with pore size, flow rate and substrate 
thickness with regards to ionization efficiency and reveal that analytes with a positive charge 
around physiological pH tend to be less sensitive to paper properties with regards to ionization 
efficiency.  An evaluation of the detection limits for the ten analytes using combinations of 
acetonitrile and methanol with 3MM chromatography paper and grade 4 filter paper showed that 
lowering detection limits using paper spray-MS is more complicated than minimizing a specific 
matrix effect and that different analytes will have different optimal detection limits.  However, the 
optimizing the paper and solvent for ionization efficiency when using a urine matrix did improve 
signal intensity for most analytes uncharged at physiologic pH and noticeably improved detection 
limits for AB-CHMINACA and alprazolam.  The solvent choice appeared to cause a much more 
significant change than the paper with acetonitrile being better for ionization efficiency than 
methanol. 
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 USING SESAME SEED OIL TO PRESERVE AND 
CONCENTRATE CANNABINOIDS FOR PAPER SPRAY MASS 
SPECTROMETRY 
4.1 Abstract 
 Cannabinoids present a unique set of analytical challenges.  An increasing number of states 
have voted to decriminalize recreational marijuana use, creating a need for new kinds of rapid 
testing.  At the same time, synthetic compounds with activity similar to THC, termed synthetic 
cannabinoids, have become more prevalent; posing a separate set of health risks.  A rapid method 
capable of detecting both natural and synthetic cannabinoids would be useful in cases of driving 
under the influence of drugs, where it might not be obvious whether the suspect consumed 
marijuana, a synthetic cannabinoid, or both.  Paper spray mass spectrometry is an ambient 
ionization technique which allows for the direct ionization of analyte from a biofluid spot on a 
piece of paper.  Natural cannabinoids like THC, however, are labile and rapidly disappear from 
dried sample spots, making it difficult to detect them at clinically relevant levels.  Presented here 
is the development of a protocol to concentrate and preserve cannabinoids in urine and oral fluid 
on paper that can subsequently be analyzed using paper spray mass spectrometry to detect THC 
and synthetic cannabinoids simultaneously.  Sesame seed oil is investigated both as a means of 
preserving THC and as part of a technique, termed paper strip extraction, wherein urine or oral 
fluid is flowed through an oil spot on a strip of paper to preconcentrate cannabinoids.  This 
technique has been shown to preserve THC in a spot for at least 27 days at room temperature, and 
is capable of detecting THC and synthetic cannabinoids at low ng/mL concentrations, making it 
suitable as a rapid screening technique.  The technique has been adapted to be used with a 
commercially available autosampler. 
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4.2 Introduction 
Cannabinoids, both natural and synthetic, have become increasingly important analytical 
targets.  Marijuana and cannabidiol oil for recreational use in the United States has been 
decriminalized in an increasing number of states1-2.  Concurrently the use of synthetic 
cannabinoids (SCs) has increased.  Synthetic cannabinoids are synthetically manufactured 
compounds that mimic the active ingredient of marijuana tetrahydrocannabinol (THC) in structure 
or function3-4.  Both types of cannabinoids raise a host of legal and health issues with their 
increased use.  Cannabis has been shown to impact psychomotor skills associated with driving, 
and the effects are amplified when combined with alcohol. States must find effective methods to 
detect THC and its metabolites in suspected Driving Under the Influence of Drugs (DUID) 
incidents5-7.  In addition, rapid and sensitive testing is needed for a variety of other applications 
such as employment testing.  As of 2015, drug abuse violations made up the highest number of 
arrests in the United States with marijuana possession making up the largest percent of these 
arrests8.  SCs represent a different set of challenges.  These compounds are applied to dried plant 
material marketed as incense “not for human consumption9.”  The dosage and potency are poorly 
understood, as the compounds come from a library generated during research into cannabinoid 
receptor agonists for pharmaceutical purposes9-10.  As a result, the risk of unpredictable side effects 
and overdose are higher, and users cannot know the exact compound they consumed. 
Historically, drug testing for marijuana use has been done in urine, and targets THC 
metabolites; commonly 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH). Detection 
typically starts with an immunoassay for screening followed by gas chromatography-mass 
spectrometry (GC-MS) for confirmation11-12.  Liquid chromatography (LC)-MS is another 
potential technique, while alternate matrices for detection include blood, plasma, hair or oral fluid1, 
13-14.  Synthetic cannabinoids pose a problem for these traditional methods.  Due to the large 
84 
 
 
number of potential compounds and the wide variation in potency, immunoassays are not sensitive 
or selective enough15.  While chromatography methods combined with mass spectrometry are 
sensitive and selective, they often require extensive sample preparation, special training, and 
lengthy analysis times.  A faster and easier technique would be beneficial as cannabinoid use 
increases. 
Paper spray MS is a potential solution, but, cannabinoids pose problems for several reasons.  
For both natural and synthetic cannabinoids, the concentration in biofluids can be low and 
detection limits for paper spray are affected by matrix effects5, 13, 16-17.  This is especially 
problematic for THC and similar compounds, which are labile and degrade rapidly in dried spots 
through a number of pathways including photo and thermal degradation18.  Attempts to improve 
detection limits of paper spray have included adding a solid phase extraction component to a paper 
spray cartridge19, performing a solvent extraction from the biofluid on top of hydrophobic paper20 
and utilizing a membrane to filter out red blood cells from whole blood21.  These methods can help 
lower detection limits, but can also increase the cost or complexity of the analysis.  Ideally, the 
detection limits of paper spray for cannabinoids could be improved by concentrating and 
preserving the analytes without drastically increasing the cost of the analysis or difficulty to 
analyze the sample. 
Herein we present a simple method to preserve and concentrate certain analytes for paper 
spray MS.  Sesame seed oil, the vehicle used for the synthetic THC dronabinol22, was evaluated 
for its ability to preserve cannabinoids in urine and oral fluid dried spots.  Theoretically, 
hydrophobic THC would concentrate in the oil.  To this end paper strips with and without sesame 
seed oil at one end were evaluated the ability to concentrate analytes as urine wicked through the 
oil coated paper.  A subset of analytes was selected to include both natural and synthetic 
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cannabinoids as well as other pharmaceuticals with varying physical properties.  After the sample 
flowed through the oil spot, the paper strip was cut into pieces and analyzed for drug distribution 
throughout the strip.  Long term preservation was evaluated by finding the detection limits of 
analytes after 1, 7, and 27 days of storage at room temperature in the dark.  Paper strip extraction 
was also compared to normal paper spray to determine if extraction improved detection limits.  
Finally, paper strip extraction was incorporated into a disposable cartridge and analyzed on a 
commercial autosampler to show the potential of the technique for rapid analysis.  
4.3 Materials 
 Analytes and their stable isotopic labels (SIL), except atenolol D7 and the synthetic 
cannabinoids, were obtained from Cerilliant (Round Rock, TX, U.S.A.).  Atenolol D7 was 
obtained from CDN isotopes (Pointe-Claire, QC, Canada) as a powder (≥98% purity).  AB-
CHMINACA, AB-CHMINACA metabolite 4, 5-fluoro ADB, 5-fluoro ADB metabolite 2 and 
AM-2201 and the SIL’s of AB-CHMINACA and AM-2201 were obtained from Cayman Chemical 
(Ann Arbor, MI, U.S.A).  HPLC grade methanol, acetonitrile, palmitic acid, linoleic acid and oleic 
acid came from Fisher Scientific (Waltham, MA, U.S.A.).  Concentrated sulfuric acid came from 
EMD Millipore (Burlington, MA, U.S.A.).  Whatman grade 31 ET and 3MM chromatography 
paper came from GE Healthcare Life Sciences (Pittsburgh, PA, U.S.A.).  Sesame seed oil, 
sesamolin, mineral oil and butylated hydroxytoluene came from Sigma-Aldrich (St. Louis, MO, 
U.S.A.).  Sesamin came from ApexBio (Taiwan). The top half of the autosampler cartridge was 
3D printed using a polypropylene filament using an Ultimaker 2+ extended from Ultimaker 
(Geldermalsen, Gelderland, Netherlands).  The bottom half of the autosampler cartridge was 
produced by Prosolia (Indianapolis, IN, U.S.A.).  Urine and saliva were provided by a single 
volunteer. 
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4.4 Methods 
4.4.1 Sesame Oil Preservation 
 The ability of sesame oil to preserve different cannabinoids overnight was evaluated 
relative to oleic acid, a major component of sesame seed oil23, and mineral oil.  Fentanyl was 
included as a non-cannabinoid analyte comparison.  Urine was spiked at 1 µg/mL for (−)-trans-
Δ⁹-tetrahydrocannabinol (THC), 11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC), 11-Nor-9-
carboxy-Δ9-tetrahydrocannabinol (THC-COOH), 11-Nor-9-carboxy-Δ9-THC glucuronide (THC 
glucuronide), AB-CHMINACA, AM-2201 and fentanyl in a glass vial (structures in Figure 4.1).   
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Figure 4.1: Cannabinoid Structures.  Structures for THC, THC metabolites and synthetic 
cannabinoids. 
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Samples were spotted in 5 µL aliquots using a glass capillary onto 5 mm x 5 mm squares of 31ET 
chromatography paper, with and without 5 µL of the different oils, and allowed to dry for 1 hour 
or 1 day at room temperature on the counter.  After drying, sample squares were spotted with 2.5 
µL of methanol containing 500 ng/mL of the stable isotopic labels (SILs) THC D3, THC-COOH 
D3, AB-CHMINACA D4, AM-2201 D5 and fentanyl D5 in methanol.  THC glucuronide and 11-
OH-THC used THC D3 for an internal standard. 
 Analysis was carried out using a holder to minimize contact between plastic and paper as 
described in previous work (Figure 3.4)17.  The holder supports an Eppendorf tip that holds solvent 
and an alligator clip that holds the sample square and paper tip. The paper tip was positioned in 
front of the inlet of a Thermo Fisher Scientific Q-Exactive Focus orbitrap mass spectrometer and 
60 µL of solvent, 80:20 acetonitrile: methanol with 25 mM sulfuric acid22, was added to the 
Eppendorf tip.  After the solvent flowed through the sample square to the paper spray tip clipped 
beneath it, 4.5 kV of voltage was applied via a secondary alligator clip for 1 minute.  The 
instrument was run in parallel reaction monitoring (PRM) mode and the area under the curve for 
the most abundant fragment for each compound was integrated.  The ratios of the area under the 
curve for the analyte divided by its SIL were found and compared between samples dried for 
different lengths of time and with different oils.   
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Figure 4.2: Natural and Synthetic Sesame Seed Oil.  Sesame seed oil (left) and synthetic sesame 
seed oil (right). 
 
 
 
Figure 4.3: Paper Strip Extraction.  Top: Urine was flowed throw an oil spot on a strip of paper.  
Middle: After drying the first 5 mm of strip was cut off and analyzed. Bottom: After drying the 
extraction strip was cut into 5 mm increments and each segment analyzed.  
 
  
Oil Region
Urine
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To determine if the antioxidants in sesame seed oil were the primary source of preservation of 
THC, a synthetic sesame seed oil was prepared by mixing the fatty acids that make up over 90% 
of sesame seed oil: oleic, linoleic and palmitic together in a 48:37:8 ratio.  This oil, (Figure 4.2), 
was tested for its ability to preserve (−)-trans-Δ⁹-tetrahydrocannabinol (THC) and its metabolites 
11-Hydroxy-Δ9-tetrahydrocannabinol (OH-THC) and 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol 
(THC-COOH).  The experiment was carried out as described in the methods section “Sesame Oil 
Preservation” except instead of sesame seed oil, synthetic sesame seed oil with a relevant % by 
weight of antioxidant present.  The naturally occurring antioxidants were spiked in at 
concentrations similar to natural sesame seed oil: 0.6% sesamin, 0.5% sesamolin or both sesamin 
and sesamolin (same %)23.  The food preservative butylated hydroxytoluene (BHT) was included 
as a synthetic alternative. 
 To analyze larger volumes of urine, samples were prepared using a technique termed paper 
strip extraction.  Strips of 3MM chromatography paper were cut into 5 mm x 40 mm strips, and 
2.5 µL of sesame seed oil was spotted at one end of each strip.  Using a glass capillary, 50 µL of 
spiked urine was applied to the end of the strip containing the sesame oil and allowed to dry.  After 
drying the first 5 mm segment of the strip was removed for analysis (Figure 4.3). 
The ability for sesame seed oil to preconcentrate THC and other hydrophobic analytes was 
evaluated.  Urine was spiked at 100 ng/mL for atenolol, alprazolam, carbamazepine, diazepam, 
gabapentin, fentanyl, AB-CHMINACA, AM-2201, THC glucuronide and THC.  Paper strip 
extraction was carried out using 50 µL aliquots of the urine followed.  After drying, the strips were 
then cut into 5 mm increments (Figure 4.3), and each segment was spiked with 5µL of a 500 ng/mL 
solution of the SILs: THC D3, THC-COOH D3, AB-CHMINACA D4, AM-2201 D5 and fentanyl 
D5 in methanol.  The individual squares were analyzed by paper spray and the ratio between the 
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analyte and the SIL was plotted as a function of distance traveled through the paper strip.  Three 
strips were analyzed with and without sesame seed oil and the results were averaged.  The list of 
analytes for this experiment included drugs with a range of logP values to determine if it was a 
factor in determining whether an analyte preconcentrated. 
 The preservation capabilities of sesame oil were evaluated over prolonged storage.  A 
calibration curve was generated in urine spiked at 0.5, 5, 10, 100, 500 and 1000 ng/mL for THC, 
11-OH-THC, THC-COOH, AB-CHMINACA, AM-2201, and fentanyl.  The internal standard was 
a SIL spiked into each calibrator at 100 ng/mL.  Two replicates were extracted and analyzed for 
each concentration as well as three blanks.  Calibration curves with or without sesame oil were 
analyzed after 1, 7, and 27 days.  Samples were stored in the dark at room temperature in a loosely 
covered plastic dish.  The slope and Y-intercept were determined by linear regression24 with a 
weighting factor of 1/X2.  Samples showing no signal or signal lower than three standard deviations 
above the average blank signal were omitted.  Detection limits were calculated as three times the 
standard error of the Y-intercept divided by the slope. 
4.4.2 Preconcentration Effects on Detection Limits 
 Samples were prepared in oral fluid and urine by either using paper strip extraction or direct 
spotting on paper for a total of four combinations to determine whether this method made a 
noticeable impact on detection limits.  Urine was spiked at 0.5, 5, 25, 100, 500 and 1000 ng/mL 
of THC, 11-OH-THC, THC-COOH, AB-CHMINACA, AM-2201, 5F-ADB and AB-
CHMINACA metabolite 4 (structures in Figure 4.1) and 100 ng/mL SIL for each analyte except 
11-OH-THC and THC-COOH which used the SIL for THC.  Paper strip extraction was carried 
out as described earlier and direct spotting was done by spotting 5 µL directly onto 5 mm segments 
of paper.  For samples prepared with oil but without paper strip extraction, a strip of paper with oil 
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was prepared as normal, after the oil distributed on the paper the first 5 mm segment was removed 
and spiked with urine.  Two replicates at each concentration and three blanks were analyzed after 
1 and 28 days to evaluate the effects of preconcentration and preservation. 
4.4.3 Automated Analysis 
 To prove the technique could be used for rapid screening, a prototype disposable cartridge 
was designed to be analyzed using a commercially available autosampler.  The cartridge consisted 
of two parts that snapped together around the sample square and paper spray tip.  The bottom half 
and steel ball bearing, used as an electrical contact, from the original autosampler cartridge were 
used with a 3D printed top modeled in Sketchup and printed using polypropylene filament on an 
Ultimaker 2 extended+.  5-fluoro ADB metabolite 2 was analyzed in addition to the analytes 
mentioned earlier (structure in Figure 4.1). 
4.5 Results and Discussion 
4.5.1 Sesame Oil Preservation 
 (−)-trans-Δ⁹-tetrahydrocannabinol (THC) and its metabolites can be difficult to analyze 
because they are unstable. Additionally, due to their hydrophobicity, a significant portion of  THC 
can be lost from aqueous matrices like urine to plastic containers18.  Dronabinol, the synthetic 
version of THC sold for pharmaceutical purposes, uses sesame seed oil to preserve THC for 
extended periods of time at room temperature22.  To determine whether this preservation could be 
extended to urine spots, sesame seed oil was added to the paper used to store the sample.  Two 
additional oils were also tested as a comparison to determine whether sesame seed oil is 
specifically required, or if the major component of sesame seed oil, oleic acid, or a non-fatty acid 
oil, mineral oil, would also preserve THC.  The amount of analyte remaining was measured as a 
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relative amount compared to the SIL spotted shortly before analysis.  Preservation was measured 
by determining the percent decrease between samples that were dried for an hour and samples that 
were dried for a day (Table 4.1).   
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Table 4.1: Decrease in Drug Concentrations Using Three Oils for Preservation.  Percent change 
in analyte signal (relative to freshly spotted internal standard) for dried urine samples after 24 
hours storage versus one hour. 
Analyte  No Preservative Sesame Oil Oleic Acid Mineral Oil 
THC -92% -7% -100% -95% 
11-OH-THC -89% -32% -100% -71% 
THC-COOH -88% -6% -96% -53% 
AB-CHIMINACA -16% -12% -41% -19% 
AM-2201 -29% -16% -23% -42% 
Fentanyl -34% 7% -25% -29% 
 
 
 
 
 
Table 4.2: Decrease in Drug Concentrations Using Different Antioxidants in Synthetic Sesame 
Seed Oil for Preservation.  Decrease in sample present measured by the decrease in ratio between 
the analyte and stable isotopic label (SIL) when the SIL is spotted immediately after the sample 
compared to a when the SIL is spotted a day after the sample. 
 
  
 THC OH THC COOH THC 
No Oil -100% -100% -100% 
Synthetic Sesame Oil (SSO) -93% -89% -99% 
SSO+Sesamin -92% -86% -100% 
SSO+Sesamolin -93% -80% -100% 
SSO+Sesamin+Sesamolin -98% -93% -100% 
SSO+BHT -93% -26% -97% 
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Without oil, THC and its metabolites showed a significant drop over the course of a day while the 
two synthetic cannabinoids and fentanyl did not, indicating that the synthetic drugs were more 
stable than the natural cannabinoids in the dried urine spot.  Of the three oils tested, only sesame 
seed oil effectively preserved THC.  Sesame seed oil is a mixture of fatty acids, antioxidants and 
other natural products23, 25.  A previous study on dronabinol indicated that the antioxidants within 
the oil likely helped THC preservation22.   
To test whether antioxidants were the reason THC was preserved in dried urine spots, a 
mixture of oleic, linoleic and palmitic acid in a similar ratio as sesame seed oil was tested.  The 
synthetic sesame seed oil was spiked either with the naturally occurring antioxidants sesamin and 
sesamolin or with the food preservative butylated hydroxytoluene and compared to the same oil 
without antioxidants (Table 4.2).  As shown in table 4.2, no combination of the naturally occurring 
antioxidants combined with synthetic sesame seed oil preserved THC or its metabolites to any 
significant amount.  This could mean that there are other components of sesame seed oil that help 
preserve THC.  There is a distinct color to natural sesame seed oil that is not present in the synthetic 
(Figure 4.2) which suggests that the synthetic sesame seed oil is missing components to make it as 
similar as possible to natural sesame seed oil.  An alternate option is that there could be an impurity 
in the oils that is preventing the antioxidants from functioning.  What is out of the ordinary is that 
OH-THC was preserved, at least partially, in synthetic sesame seed oil with BHT.  Given the 
complex nature of natural oils it would be a labor intensive process to narrow down the exact 
source of sesame seed oils preservation of THC which is beyond the scope of the current work.  
 The fact that THC adsorbs onto plastic container walls from urine prompted the idea that 
it could be extracted from urine as it flows through a hydrophobic matrix, such as sesame seed oil 
on a strip of paper.  This process is referred to here as paper strip extraction (Figure 4.3).  This 
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method of extraction was evaluated with a variety of analytes with varying logP values to 
determine how they would distribute (Figure 4.4).   
The cannabinoids (THC, THC glucuronide, and both synthetic cannabinoids) decreased 
significantly by the third segment (10-15 mm) regardless of the presence of sesame seed oil on the 
paper.   All the other analytes except for diazepam had a more uniform distribution throughout the 
paper strip regardless of the presence of oil.  Diazepam showed an even distribution without oil 
but was more concentrated in the first 10 mm with oil.  The distribution of the drugs was not 
strictly determined by hydrophobicity.  While all the molecules that concentrated at the head of 
the strip are hydrophobic, the fact that the more hydrophilic THC glucuronide also concentrated 
suggests additional interactions played a role.  This meant that there were two potential 
mechanisms for improving detection limits using paper strip extraction; preservation from sesame 
seed oil and preconcentration of hydrophobic analytes.  To determine the extent that preservation 
plays on detection limits over time sets of calibration curves were prepared by paper strip 
extraction with and without sesame seed oil.  Extraction was carried out and the 5 mm sample 
segments were stored at room temperature in a drawer for 1, 7 and 27 days then analyzed to 
determine the change in detection limits over time.  The preservation effects of sesame seed oil 
are best illustrated by looking at the calibration curves for THC without sesame seed oil before 
and after 27 days of storage (Figure 4.5: A1 and A2 respectively) compared to with sesame seed 
oil over the same length of time (Figure 4.5: B1 and B2 respectively).   
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Figure 4.4: Preconcentration During Paper Strip Extraction with and without Sesame Seed Oil.  
Decrease in analyte concentration throughout a strip of paper with or without sesame seed oil at 
the end.  Measurements expressed as a percentage of the analyte/SIL ratio for that segment 
relative to the ratio in the first 5 mm segment. 
 
 
Figure 4.5: Calibration Curves for THC Before and After 27 Days of Storage With and Without 
Sesame Seed Oil.  Calibration curves for THC after 1 day (A1 and B1) and after 27 days (A2 and 
B2) using paper strip extraction (A1 and A2) and paper strip extraction with sesame seed oil (B1 
and B2).  
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By day 27 the calibration curve without oil (Figure 4.5A2) shows only two detectable 
concentrations, while the curve with sesame seed oil (Figure 4.5B2) still shows signal down to 10 
ng/mL, demonstrating a marked improvement in stability for THC.  The detection limits for the 
analytes were found at different time intervals (Table 4.3).  Fentanyl was included as a non-
cannabinoid comparison. 
The synthetic cannabinoids showed minimal change over time, with or without the addition 
of oil.  THC and 11-OH-THC show a measurable increase in the lowest detectable concentration 
over time without sesame seed oil.  THC-COOH showed significant degradation over time even 
with sesame seed oil, albeit still improved over no preservative.   
4.5.2 Preconcentration Effects on Detection Limits 
 In the previous section it was shown that sesame seed oil preserves THC, but doesn’t 
investigate the effects of preconcentration.  The fact that in table 4.3, THC still had a low ng/mL 
detection limit with extraction but without sesame seed oil after 24 hours, while in table 4.1 over 
90% of THC directly spotted on paper was gone in the same amount of time suggests that 
preconcentration could significantly improve detection limits.  To test the effects of 
preconcentration on detection limits and preservation, biofluids were stored on paper with sesame 
seed oil with and without preconcentration and analyzed after 1 day and 28 days (Table 4.4).  Oral 
fluid was added as a second non-invasive biofluid (Table 4.5). 
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Table 4.3: Detection Limits Over Time in Urine Using Paper Strip Extraction.  Lowest detectable 
urine concentration (ng/mL) after paper strip extraction with and without sesame seed oil after 
storage at room temperature.  *Detection limits significantly above the 100 ng/mL internal 
standard are rough estimates. 
Analyte 
Day 1 Day 7 Day 27 
No Oil Oil No Oil Oil No Oil Oil 
THC 2 1 30 1 ≥500* 3 
11-OH-THC 20 4 30 4 ≥1000* 4 
THC-COOH 10 5 130 30 ≥1000* 120 
AM-2201 0.8 1 1 0.6 4 0.8 
AB-CHMINACA 1 3 1 1 3 2 
Fentanyl 2 3 0.8 3 2 7 
 
 
 
Table 4.4: Urine Detection Limits Over Time With and Without Paper Strip Extraction.  Lowest 
detectable urine concentration (ng/mL) with and without paper strip extraction after storage at 
room temperature with sesame seed oil. *Detection limits well above the 100 ng/mL internal 
standard are rough estimates. 
Urine 
Day 1 Day 28 
Without 
Concentration 
With 
Concentration 
Without 
Concentration 
With 
Concentration 
THC 20 2 10 2 
11-OH-THC 9 4 70 20 
THC-COOH 200 10 ≥500* 40 
AM-2201 0.2 0.2 0.2 0.2 
AB-CHMINACA 1 0.2 1 2 
AB-CHMINACA M4 130 60 70 80 
5F-ADB 2 0.3 0.3 0.3 
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Table 4.5: Oral Fluid Detection Limits Over Time With and Without Paper Strip Extraction.  
Lowest detectable oral fluid concentration (ng/mL) with and without paper strip extraction after 
storage at room temperature with sesame seed oil. *Detection limits well above the 100 ng/mL 
internal standard are rough estimates. 
 
 
 
 
Table 4.6: Autosampler Detection Limits.  Detection limits in ng/mL in oral fluid using sesame 
seed oil and paper strip extraction in a half 3D printed autosampler cartridge. 
  
Oral Fluid 
Day 1 Day 28 
Without 
Concentration 
With 
Concentration 
Without 
Concentration 
With 
Concentration 
THC 20 1 30 1 
11-OH-THC 4 3 70 5 
THC-COOH 10 3 ≥1000* 60 
AM-2201 0.06 0.08 0.2 0.08 
AB-CHMINACA 4 0.6 3 2 
AB-CHMINACA M4 50 100 100 100 
5F-ADB 2 0.2 2 0.2 
Analyte LOD 
THC 4 
5F-ADB 0.1 
5F-ADB M2 0.5 
AB-CHMINACA 6 
AM-2201 0.1 
AB-CHMINACA M4 20 
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Tables 4.4 and 4.5 show a noticeable improvement to detection limits from preconcentration for 
THC.  THC-COOH behaved as in table 4.3; showing heightened detection limits after 28 days, 
even with oil.  However, for both THC-COOH and 11-OH-THC without preconcentration, there 
was an increase in detection limits after 28 days for both biofluids.  This suggests that there is a 
secondary mechanism for the elimination of the two THC metabolites that isn’t abated by 
preconcentration or sesame seed oil.  The metabolite AB-CHMINACA M4, which is more 
hydrophilic than AB-CHMINACA, showed worse detection limits than AB-CHMINACA under 
all conditions.  The fact that the three metabolites studied show worse results than the original 
analytes suggest that paper strip extraction with sesame seed oil is less effective for metabolites.  
This could be due to metabolites typically being less hydrophobic than the original analyte.  
However, the detection limits for THC without preconcentration ranged from 10-30 ng/mL while 
with preconcentration the limit ranges between 1-2 ng/mL; showing that preconcentration does 
lower detection limits, for certain analytes.  AM-2201 and AB-CHMINACA had consistent results 
regardless of the biofluid, preconcentration, or storage time.  5F-ADB in most cases showed about 
an order of magnitude improvement in its detection limit when performing paper strip extraction.  
These results suggest that paper strip extraction has the potential to improve the detection limits 
for synthetic cannabinoids relative to directly spotting the analyte on paper, but it is not consistent 
and is analyte dependent.  More importantly, the detection limits for the synthetic cannabinoids 
did not get worse with the addition of oil, meaning that both natural and synthetic cannabinoids 
can be detected with the same method. 
4.5.3 Automated Analysis 
 The main attractions of paper spray mass spectrometry are its ease of use and short analysis 
times.  Any modifications to the technique should maintain the speed and simplicity of the 
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technique; otherwise those modifications defeat the purpose of paper spray.  Ideally, the analysis 
would also compatible with automation to enable high throughput analysis.  A prototype paper 
spray cartridge was developed to demonstrate the potential for simple, fast, and automated 
implementation of paper strip extraction.  The top half of the cartridge was 3D printed in 
polypropylene (top part of Figure 4.6:A) and the bottom half came from an injection molded paper 
spray autosampler cartridge (bottom part of Figure 4.6:A). Polypropylene was selected for the top 
half due to its resistance to organic solvents.  When the top half was snapped onto the bottom half, 
it made a seal around the sample square such that solvent flowed through the sample to the paper 
spray substrate.   
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Figure 4.6: Prototype Paper Strip Extraction Cartridge.  A. 3D printed polypropylene top half 
and injection molded plastic bottom half, B. assembled cartridge. 
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A calibration curve was generated using the prepared cartridges to determine; the LOD calculated 
from the calibration curves are shown in table 4.6. THC-COOH was also run in this experiment, 
but there were insufficient data points for a calibration curve.  This was unexpected because THC 
analysis performed similarly to previous experiments.  The three synthetic cannabinoids and two 
metabolites likewise behaved similarly.  It’s possible that some interferent eluting from the 3D 
printed plastic specifically affected THC-COOH ionization.   Beyond this anomaly the 
autosampler cartridge results showed that the paper strip extraction technique is compatible with 
automation. 
Paper strip extraction was evaluated here as a means of analyzing natural and synthetic 
cannabinoids.  As the detection limits for synthetic cannabinoids were not significantly worse 
when comparing paper strip extraction to direct spotting (Tables 4.4 and 4.5), nor were they 
significantly worse after extended storage (Tables 4.3-4.5), the usefulness of paper strip extraction 
lies in having a technique capable of simultaneous and rapid detection of both synthetic and natural 
cannabinoids. To be a valid option for routine analysis for applications such as determining driving 
under the influence of drugs (DUID) or workplace drug screening, the technique must be sensitive 
enough to at least detect levels indicative of recent use in that specific biofluid.  Current workplace 
drug testing methods typically focus on THC-COOH as a biomarker in urine with cut offs at 50 
ng/mL for the initial screen and 15 ng/mL for the subsequent confirmation11.  Looking at the paper 
strip extraction results for THC-COOH, there is a discrepancy between the detection limits for 
multiple experiments under similar experimental conditions.  Also, the results were significantly 
worse in oral fluid and when using an automated cartridge.  Considering the results in table 4.3, 
THC-COOH detection limits got noticeably worse over time relative to THC, indicating that THC-
COOH was unstable in the urine spot even with sesame seed oil (even if the degradation was 
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slower than without oil).  This result casts doubts on using paper strip extraction for routine 
detection of THC-COOH.  However, THC-COOH is a metabolite that can be present for days in 
biofluids at variable levels over time depending on the frequency of use26, and thus is not a good 
marker on its own for determination of recent use in cases of DUID5.  For recent use, it has been 
proposed that THC itself is a better biomarker, as its presence in biofluid spikes within a few hours 
of use and drops off quickly27-29.  For urine samples, the low ng/mL detection limits obtained by 
paper strip extraction are close to the 1.5 ng/mL cut-off proposed as an indication of recent use28.  
For oral fluid, the concentration of THC can vary quite a bit after recent use27, but the cut-off 
concentration for THC from Substance Abuse and Mental Health Services Administration 
(SAMHSA) is 2 ng/mL30 and the cut-off for DUID from the European Union’s Driving Under the 
Influences of Drugs, Alcohol, and Medicines (DRUID) are 1 ng/mL31.  This also lies within the 
range detectable by paper strip extraction, although some further refinement of the technique and 
improvement in the detection limits are needed to decrease false negatives for samples near the 
cut-off value.  Still, paper spray coupled to paper strip extraction represents a new opportunity to 
rapidly screen for both synthetic and natural cannabinoids from urine or oral fluid samples. 
4.6 Conclusion 
 A method of concentrating and preserving THC and its metabolites in urine or oral fluid 
spots was demonstrated and integrated into cartridge compatible with a paper spray autosampler.  
By flowing urine or oral fluid through paper, synthetic and natural cannabinoids were found 
concentrate at the head of the paper.  THC, which is normally labile and difficult to analyze from 
a biofluid spot, can be preserved for at least 27 days at room temperature with the addition of 
sesame seed oil to the paper.  Combining these two techniques improved detection limits for THC 
to ng/mL levels in urine and oral fluid, close to current cut-off values for detection in cases of 
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DUID.  This method was also able to simultaneously detect natural and synthetic cannabinoids 
from a single sample.   
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 NOVEL SOLID PHASE EXTRACTION PAPER SPRAY 
TECHNIQUES FOR DETECTING NEW PSYCHOACTIVE 
SUBSTANCES IN BLOOD, PLASMA, ORAL FLUID AND URINE.  
5.1 Abstract 
 Synthetic drugs that mimic more traditional drugs, termed designer drugs or new 
psychoactive substances, have led to an epidemic of overdose cases in recent years.  Fentanyl and 
fentanyl analogues continue to cause deaths due to their high potency.  At the same time synthetic 
cannabinoids skirt regulation and detection due to the large number of possible targets available 
from pharmaceutical research.  Traditional drug assays are either slow and elaborate, or not 
specific or sensitive enough.  Paper spray mass spectrometry (MS) offers a rapid and simple means 
to detect these different types of analytes in a variety of biofluids.  The limits of detection for paper 
spray MS, however, are often inadequate for synthetic drugs due to the higher potency of these 
molecules.  Previous work has shown that integrating solid phase extraction (SPE) into a paper 
spray cartridge significantly improves limits of detection.  The addition, however, increases the 
complexity and the cost of disposable cartridges, and is incapable of analyzing more viscous 
biofluids like whole blood.  In this work, solid phase extraction powder was mixed with corn starch 
to make a porous and rugged solid that can be used with paper spray.  This solid was coated on the 
end of a strip of paper and used to extract drugs from plasma, oral fluid and urine to improve 
detection limits for new psychoactive substances and a selection of prescription drugs with known 
physical properties.  To analyze whole blood, the SPE solid was combined with a commercially 
available autosampler cartridge and a lateral blood fractionation paper was used to pull the blood 
through the solid.  Certain analytes showed improvements to limits of detection ranging from a 
factor of 5 to over a factor of 50. 
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5.2 Introduction 
 New psychoactive substances (NPS), also called synthetic or designer drugs, are similar to 
historically more common drugs in structure or function and have been causing problems in the 
United States and around the world in recent years1-3.  These drugs have unique structures from 
their more well-known counterparts, making them more difficult to detect and regulate1.  A 
majority of the deaths are caused by opioid overdoses from compounds such as fentanyl and 
fentanyl analogues3-4.  These analogues can have potencies that range over several orders of 
magnitude4-5, making it is easy to overdose if the dosage isn’t well controlled or if heroin is cut 
with fentanyl6.  This has led to drug poisoning being the number one cause of injury death in the 
United States in recent years6. Another class of NPS, synthetic cannabinoids, present a different 
problem in that there are libraries of compounds available left over from pharmaceutical research 
into cannabinoids7.  These compounds are sprayed on dried plant material and marketed as incense 
“not for human consumption8.”  The dosage of these compounds is often poorly controlled, the 
potency of each compound has not been studied, and there are unknown side effects.  All of these 
factors can cause patients to end up in the emergency room with an overdose on an unknown 
substance8. 
 Traditionally, analysis of drugs of abuse involves an immunoassay screening step, followed 
by either gas or liquid chromatography paired with a detector9-12.  However, immunoassays are 
insufficient for screening in the new crisis.  The lethal concentrations of more potent NPS are often 
below what immunoassays can detect in complex matrices like blood13.  Immunoassays are also 
not selective enough to tell different analogs apart from each other, nor are they able to easily 
implement multiplexing to determine whether multiple drugs are present13.  Chromatography 
paired with different detectors can have the required sensitivity and specificity, but is problematic 
for high throughput screening because it requires extensive sample preparation followed by a time-
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consuming chromatography run.  This adds time and training requirements to the procedure as 
well as cost.  There is a clear need for methods that are fast, cheap, simple, sensitive, and have 
high specificity. 
 Paper spray mass spectrometry (MS) is fast, cheap and simple, but, a major concern is 
increased limits of detection due to the presence of matrix effects14.  Biofluids are complex 
matrices containing high concentrations of salts and biomolecules which are still present when the 
biofluid is directly analyzed.  In previous work, the properties of the paper were studied to 
determine if these matrix effects could be mitigated, but careful selection of the paper only had a 
small improvement on detection limits for certain biofluids15-16.  Alternatively, extracting analytes 
either through a liquid extractions of the biofluid on hydrophobic paper17 or solid phase extractions 
(SPE) using a cartridge with a built in SPE component18 has been shown to noticeably lower 
detection limits.  Rapid ambient ionization techniques that utilize solid phase extractions aren’t 
limited to paper spray either.  Coated blade spray techniques use a bound stationary phase on metal 
blades to extract analytes from biofluid to achieve pg/mL detection limits for certain analytes19-20.  
Preparing these blades, however, requires an offline extraction step which also increase method 
complexity.  In addition, solid phase extraction techniques have difficulties with viscous biofluids 
like blood.  This is because SPE extraction of whole blood normally requires extensive work such 
as centrifugation, protein precipitation or dilution prior to the extraction21-22.  In addition, adding 
SPE to paper spray increases the complexity of the autosampler cartridge and the analysis.  
 In this work, a new and easier means of concentrating analytes out of biofluids using SPE 
powder is investigated and combined with paper spray-MS.  SPE powder is mixed with a corn 
starch binder to make a porous solid and coated on the end of a strip of chromatography paper.  
Plasma, oral fluid and urine are passed through the SPE region to concentrate analytes out of the 
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biofluid, a subsequent rinse helps mitigate matrix effects.  Limits of detection were determined 
and compared to unmodified paper spray-MS analysis of each biofluid.  Whole blood was found 
to be incompatible with this SPE paper strip extraction approach, so a different technique was 
developed for whole blood.  Undiluted whole blood was extracted vertically through a SPE solid 
contained in an autosampler cartridge to a waste pad designed to help wick blood.  Extracted whole 
blood was rinsed both while wet and after drying and the limits of detection determined relative to 
directly spotting in the autosampler cartridge.  Finally, a design for a paper spray autosampler 
cartridge with built in SPE strip extraction was assembled as a proof of concept using parts from 
a commercially available cartridge combined with 3D printed components. 
5.3 Materials 
 Analytes and their stable isotopic labels (SIL), except atenolol D7 and the synthetic 
cannabinoids, were obtained from Cerilliant (Round Rock, TX, U.S.A.).  Atenolol D7 was 
obtained from CDN isotopes (Pointe-Claire, QC, Canada) as a powder (≥98% purity).  AB-
CHMINACA and AM-2201 and their SIL’s were obtained from Cayman Chemical (Ann Arbor, 
MI, U.S.A).  Pooled human plasma, HPLC grade methanol, and acetonitrile came from Fisher 
Scientific (Waltham, MA, U.S.A.).  Whatman grade 31 ET, 3MM chromatography paper and 
grade 4 filter paper were bought from GE Healthcare Life Sciences (Pittsburgh, PA, U.S.A.).  Corn 
starch was purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).  Strata-XL SPE tubes were 
purchased from Phenomenex (Torrance, CA, U.S.A.).  CytoSep blood fractionation paper was 
donated by the Pall Corporation (Port Washington, NY, U.S.A.).  The autosampler cartridge was 
produced by Prosolia (Indianapolis, IN, U.S.A.).  The top half of the autosampler cartridge was 
3D printed using a polypropylene filament using an Ultimaker 2+ extended (Geldermalsen, 
Gelderland, Netherlands).  Delrin plastic sheets (0.35 mm thick, black) were ordered from 
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McMaster-Carr (Elmhurst, IL, U.S.A.).  Urine and saliva were provided by a single donor.  Whole 
blood was drawn from a separate donor. 
5.4 Methods 
5.4.1 Making SPE Extraction Strips and Cartridges 
 SPE extraction strips were made by coating a slurry of SPE powder and a binder onto the 
end of a strip of chromatography paper then letting it harden into a porous solid.  The slurry was 
prepared by adding boiling water in a 2:1 ratio (volume:mass) to SPE powder containing 
cornstarch at 3% by mass.  The slurry was heated by submerging the container in a boiling water 
bath for 5 minutes.  The slurry was spotted in 10 µL aliquots for oral fluid experiments and 20 µL 
aliquots for urine or plasma on the end of wet strips of 31ET chromatography paper.  The strips 
were 5x40 mm for oral fluid experiments and 15x35 mm with a 5x5mm square segment at one end 
for urine and plasma.  Adding a 5x5 mm square of grade 4 filter paper to the top of the slurry on 
the strip added another surface for the slurry to adhere to and increased ruggedness of the device 
once the slurry dried.  For whole blood extraction the top half of an autosampler cartridge was 
removed and the rear solvent well was sealed on the bottom with aluminum foil.  The well was 
filled with 10 µL of slurry and allowed to dry before removing the foil.  After drying the mixture 
of starch and SPE powder was rugged enough to be handled without fracturing.  The finished 
extration devices for oral fluid, urine or plasma, and whole blood are shown in Figure 5.1A-C 
respectively. 
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Figure 5.1: Three Different SPE Extraction Devices for Paper Spray-MS.  A) SPE strip for oral 
fluid extraction, B) SPE strip urine and plasma extraction, C) SPE in an autosampler cartridge 
for whole blood extraction.  SPE material contained under square of filter paper at the bottom of 
the strip in A and B and in the rear solvent well in C. 
 
 
 
 
Figure 5.2: Extraction of Whole Blood on an Autosampler Cartridge.  A) Top half of an 
autosampler cartridge with SPE solid contained in rear solvent well and waste pad. B) Whole 
blood flowing through SPE to waste pad. C) SPE after sample dried. D) Assembled cartridge 
after water wash step. 
  
A B C 
A B C D 
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5.4.2 Analyte Retention 
 Plasma, oral fluid and urine were extracted using the SPE strips on 3MM paper and 
analyzed to determine whether analytes were being concentrated.  Biofluids were spiked at 500 
ng/mL of the prescription drugs atenolol, carbamazepine, fentanyl and diazepam and the NPSs 
carfentanil, AB-CHMINACA and AM-2201 as well as the metabolite norfentanyl. Extraction was 
carried out by flowing 50 µL of the biofluid through the SPE region at the end of the strip.  
Following extraction and drying the strip was cut into 5 mm increments and spiked with 5 µL of 
500 ng/mL stable isotope labeled (SIL) analogs of the analytes except for norfentanyl and 
carfentanil which used fentanyl-d5. Paper spray-MS was carried out by using an alligator clip to 
attach the sample square onto a paper tip and positioning it in front of the inlet of a Thermo Fisher 
Scientific Q-Exactive Focus orbitrap mass spectrometer.  Two 30 µL aliquots of 9:1 acetonitrile: 
water with 100 ppm formic acid were added to a solvent well consisting of an Eppendorf tip 
contacting the sample square. After adding the solvent, ionization was carried out by applying 4.5 
kV of voltage to the paper for 1.7 minutes.  The MS was run in parallel reaction monitoring mode 
(PRM), measuring the MS/MS spectrum for each analyte and its SIL.  Each 5 mm increment was 
analyzed separately and the area under the curve during each run was calculated for each analyte 
and its SIL.  Drug retention was evaluated by calculating the ratio between the analyte in the square 
divided by the SIL and normalizing the value to the ratio from the first 5 mm of the strip. 
5.4.3 SPE Strip Extraction of Plasma, Oral Fluid and Urine 
 Limits of detection in different biofluids were evaluated by analyzing calibration curves 
with and without SPE extraction.  Calibration curves were prepared in plasma, oral fluid and urine 
at 0.1, 1, 10, 25, 100 and 1000 ng/mL each with a 100 ng/mL internal standard consisting of SILs.  
For each biofluid, two measurements were made at each concentration as well as three blank 
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measurements.  Extraction was carried out as described before except that 100 µL was extracted 
for plasma and urine using the paper strip with a larger width (Figure 5.1B).  After drying, the 
same volume of milli-Q water (50 µL for oral fluid, 100 µL for plasma and urine) was flowed 
through the SPE region as a clean-up step.  Direct spotting was conducted by spotting 5 µL of 
biofluid directly on a 5x5 mm square of 31ET.  After extraction and drying the first 5 mm segment 
containing the SPE material was cut from the rest of the strip and attached to a wedge of 31ET 
chromatography paper with a point using an alligator clip, and the same was done with the directly 
spotted squares.  Paper spray-MS was carried out as described earlier except that the spray solvent 
volume was increased for the SPE samples to two aliquots of 40 µL of solvent.  Ratios between 
the analyte and SIL were determined for each calibration level, and a calibration curve was 
constructed.  Any data points which were lower than three times the standard deviation of the 
blanks were excluded.  Slopes and Y-intercepts were calculated using linear regression23 with a 
weighting factor of 1/X2.  Limits of detection were set at three times the standard error in the Y-
intercept divided by the slope. 
5.4.4 SPE Cartridge Extraction of Whole Blood 
 A calibration curve was prepared as described earlier but in whole blood using an 
autosampler cartridge with SPE material in the solvent slot (Figure 5.2A).  Two aliquots of 35 µL 
of whole blood were flowed through the SPE to a waste pad consisting of three 1x1 cm squares of 
grade 1660 cytosep paper (Figure 5.2B).   
Two aliquots of 75 µL of milli-Q water was applied to the SPE, where it flowed through the SPE 
material to 31ET chromatography paper waste pads.  Cartridges were washed either while the 
blood was still wet or after two hours of drying at room temperature (Figure 5.2C).  For direct 
spotting 10 µL of blood was spotted directly on the paper inside the autosampler cartridge.  The 
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cartridges were then assembled (Figure 5.2D) and analyzed as described earlier except the solvent 
was 1:1 acetonitrile: methanol with 100 ppm formic acid. Direct whole blood analysis was carried 
out with 60 µL of spray solvent where as SPE whole blood samples used 80 µL.  Calibration curves 
and limits of detection were calculated as described previously. 
5.4.5 Prototype Cartridge for Implementation of SPE Strip Extraction 
 A cartridge with a built-in SPE strip extraction was assembled as a proof of concept.  An 
autosampler cartridge had the top half removed and replaced with a 3D printed version, (Figure 
5.3A), designed to flow biofluid and solvent through the SPE region of an extraction strip.  The 
top was modeled in Sketchup and printed using polypropylene filament on an Ultimaker 2 
extended+.  The SPE extraction strip was adhered to a 0.35 mm thick piece of Delrin plastic, 
(Figure 5.3A), and positioned on top of a paper spray tip within the cartridge (Figure 5.3B).  The 
strip was perforated with a razor blade between the SPE region and the waste strip.  The bottom 
half of the cartridge, (Figure 5.3A), had plastic cut away from one side with a razor blade to make 
room for the extraction strip.  After extraction the excess paper was removed along with the Delrin 
(Figure 5.3C). 
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Figure 5.3: SPE Strip Autosampler Cartridge.  A) The components of an autosampler cartridge 
with built in SPE strip extraction. B) The assembled cartridge. C) The assembled cartridge after 
removing the waste strip. 
  
A 
B 
C 
119 
 
 
5.5 Results and Discussion 
5.5.1 Analyte Retention 
 The first test of the SPE extractions strips was to confirm that passing biofluid through the 
SPE region retained the analytes.  To this end, three different biofluids were selected and spiked 
with fentanyl, carfentanil, and norfentanyl (a fentanyl analogue and metabolite), AB-CHMINACA 
and AM-2201 (synthetic cannabinoids) as well as the pharmaceuticals diazepam, atenolol, and 
carbamazepine.  Pharmaceuticals were included because physical and chemical properties such as 
logP and pKa are not known for many NPS; including analytes with known physical properties 
helps determine whether any observed trends are related to those properties.  After extraction and 
dividing the strip into 5 mm increments, each segment was spiked with an internal standard. The 
ratio between the analyte and the SIL IS was used to determine if the analytes were concentrated.  
A similar experiment was carried out with a strip of 3MM chromatography paper without SPE 
material as a comparison.  The 3MM paper was used instead of 31ET because 3MM was found to 
concentrate certain analytes even without SPE material, and that property needed to be considered 
when evaluating the effectiveness of the SPE coated strip.  The results were normalized to the first 
5 mm increment and the results for carbamazepine, fentanyl, and AB-CHMINACA (Figure 5.4A-
C, respectively). 
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Figure 5.4: Preconcentration Using SPE Strip Extraction.  Change in relative concentration of A) 
carbamazepine, B) fentanyl and C) AB-CHMINACA in three biofluids over the first 20 mm of a 
strip of 3MM chromatography paper with and without SPE on the first 5 mm.  All measurements 
are expressed as a percentage of the analyte amount in the first 5 mm. 
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For all three biofluids, most of the analytes showed the same trends as carbamazepine (Figure 5.4A) 
and fentanyl (Figure 5.4B); significant analyte retention was observed when the SPE material was 
present but not for plain paper.  This result indicated that, in general, the SPE material will 
preconcentrate drugs from larger sample volumes much more effectively than plain paper. AB-
CHMINACA (Figure 5.4C) and AM-2201 showed a different trend in oral fluid and urine samples.  
In these two matrices, the synthetic cannabinoids tended to concentrate on chromatography paper 
even without SPE material.  This is most likely due to the synthetic cannabinoids’ high 
hydrophobicity.  The concentration effect was still more pronounced with SPE present, however. 
In plasma samples, the synthetic cannabinoids did not show any concentration effects for plain 
paper.  This is likely because of the high protein content in plasma samples, which would have 
bound the drugs non-specifically and carried them along the strip.   
5.5.2 SPE Strip Extraction of Plasma, Oral Fluid and Urine 
 SPE extraction can lead to lower detection limits if there isn’t also an increase in matrix 
effects.  Plasma, oral fluid, and urine were extracted using the SPE paper strip and washed with 
milli-Q water to minimize matrix effects caused by water soluble components like salts.  Limits 
of detection from the SPE strip and from directly spotting the biofluids were calculated based on 
their calibration curves (Table 5.1). 
  
122 
 
 
 
 
Table 5.1: Limits of Detection in Plasma, Urine, and Oral Fluid Using SPE Strip Extraction.  
Lowest detectable concentration (ng/mL) in plasma, urine, and oral fluid when extracted using 
SPE strip and when directly spotting the biofluid on paper (no SPE). Oral fluid SPE strip 
extraction was carried out with half the amount of SPE and half the amount of biofluid volume 
as plasma or urine. 
  Plasma Urine Oral Fluid 
  SPE No SPE SPE No SPE SPE No SPE 
AB-CHMINACA 0.2 5 2 5 0.4 0.5 
Acetyl Fentanyl 0.1 2 0.01 0.1 0.01 0.02 
AM-2201 2 3 0.3 0.9 0.6 0.07 
Atenolol 0.2 10 1 4 0.5 2 
carbamazepine 0.2 3 0.2 2 0.04 0.04 
carfentanil 0.02 0.5 0.01 0.4 0.04 0.4 
Diazepam 0.2 2 2 2 0.03 0.4 
Fentanyl 0.2 1 0.02 0.2 0.03 0.03 
Norfentanyl 0.4 3 4 80 0.03 0.4 
 
 
 
Table 5.2: Detection Limits in Whole Blood after Extraction.  Limits of detection (ng/mL) for 
analytes in whole blood when directly spotted on paper (no SPE), extracted using SPE then 
washed while dry, and extracted using SPE then washed while still wet. 
  No SPE Dry wash Wet Wash 
AB-CHMINACA 1 0.3 0.2 
Acetyl Fentanyl 0.08 0.01 0.01 
AM-2201 2 0.3 0.2 
Atenolol 3 0.4 0.3 
Carbamazepine 2 0.03 0.2 
Carfentanil 0.5 0.1 0.09 
Diazepam 20 0.3 0.3 
Fentanyl 0.3 0.03 0.2 
Norfentanyl 0.7 0.7 0.4 
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Of the 27 drug-matrix combinations, 14 showed a factor of ten or more improvement for SPE strip 
extraction relative to direct paper spray MS.  For oral fluid samples, significant improvement was 
obtained for carfentanil, diazepam and norfentanyl.  Plasma and urine samples showed large 
improvements in detection limits for 11 of the drug-matrix combinations, ranging from around a 
factor 10 for acetyl fentanyl in urine and diazepam in plasma to upwards of 50 for atenolol in 
plasma.  
Sample volume is an important consideration during method development. For plasma and 
urine, 100 µL was found to give better detection limits than used because extracting only 50 µL of 
biofluid (results not shown).  There is a limit to the volume of biofluid that can be extracted by 
this method, however.  The rate of flow through the SPE material slows at higher volumes because 
the wicking rate decreases as the sample wicking distance increases24.  It is also possible that 
components of the biofluid clog the SPE material, which would have a cumulative effect at higher 
volumes.  Also, a lower sample volume was necessary for oral fluid because the enzymes in oral 
fluid degraded the starch binder; the SPE material was no longer held together and had to be 
analyzed with care not to spill the powder.  To improve robustness of oral fluid analysis by this 
method, additional research is needed to identify a water wettable binder that is not degraded by 
enzymes found in oral fluid.  Despite the lower extraction volume and the difficulty of working 
with the samples, oral fluid still showed marked improvement for three of the nine analytes. 
5.5.3 SPE Cartridge Extraction of Whole Blood 
 SPE extraction of biofluids like plasma has been shown to be an effective way to improve 
limits of detection18.  Analyzing whole blood would be faster as it wouldn’t require the added step 
of removing red blood cells.  However, whole blood is viscous and therefore difficult to flow 
appreciable quantities through SPE material. Furthermore, whole blood does not flow laterally 
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easily because it tends to clog as it travels through normal chromatography paper.  Both of these 
factor makes it incompatible with SPE strip extraction.  To overcome these problems, a setup to 
accommodate whole blood was devised (Figure 5.2). Here, whole blood was flowed vertically 
through the SPE solid contained within the solvent well of a paper spray autosampler cartridge.  
The blood sample flowed through SPE material onto a waste pad consisting of three layers of 
cytosep lateral blood fractionation paper (Figure 5.2).  This fractionation paper is a material 
designed to wick whole blood and to separate out plasma from the slower eluting red blood cells 
in the process.  The dry SPE-starch solid was found to firmly adhere to the acetal plastic cartridge 
throughout the extraction process without adhesives.  After applying blood sample, the SPE 
material was washed with milli-Q water either when the whole blood was dry or while the blood 
was still wet.  Washing removed most of the coloration of the SPE material (Figure 5.2D) and the 
limits of detection were compared to direct spotting of the whole blood as shown in table 5.2.  
Extraction of whole blood showed a consistent improvement of detection limits for most analytes.  
The washing procedure didn’t depend on whether the blood was dry or wet prior; except in the 
case of fentanyl and carbamazepine.  Washing after the whole blood was dry performed better 
relative to wet. 
5.5.4 Method Usefulness 
 Together, these methods demonstrate the ability of paper spray with integrated SPE to 
improve detection limits for synthetic cannabinoids, opioids, and pharmaceuticals in a variety of 
matrices.  To be useful, the detection limits must be close to biologically relevant concentrations.  
For synthetic cannabinoids in general this is difficult as there are many potential targets and the 
potency of each is often unknown7-8.  In 2014, two studies on AB-CHMINACA exposure found 
ranges of 0.4-14.3 ng/mL in plasma of patients experiencing acute delirium and seizures25 and 
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whole blood concentrations of 0.6-10 ng/mL in suspected impaired drivers26.  In another study 
looking at synthetic cannabinoids similar to AM-2201 in postmortem plasma samples, 
concentrations were found at 16.3, 140 and 0.86 ng/mL for MAM-2201, AM-1220 and AM-2232 
respectively27.  These studies give a rough idea of the concentration range expected for these 
specific analytes, which is in the low to sub-ng/mL range.  Looking at the results in tables 5.1 and 
5.2, the detection limits for the synthetic cannabinoids AB-CHMINACA and AM-2201 were in 
the low to sub ng/mL range for the three biofluids.  This is close to the biological concentrations, 
and the method may be suitable as a screening technique. The method needs further validation to 
be used for quantitation. For fentanyl and fentanyl analogues, the biologically relevant 
concentration range depends on the potency5.  Acetylfentanyl, for example, has been found at over 
100 ng/mL in blood samples from several intoxications and fatalities, while carfentanil has been 
found in the 0.01-0.617 ng/mL ranges5.  Looking at the results in table 5.2, the method is adequate 
for detection of acetylfentanyl with detection limits at 0.01 ng/mL, but would fail to detect 
carfentanil in cases of intoxication where whole blood concentrations are below 0.1 ng/mL.  If the 
matrix were plasma or urine, however, the detection limit would be significantly lower.  Beyond 
the two illicit drug classes of synthetic cannabinoids and fentanyl analogues a number of 
pharmaceuticals were also evaluated.  They included the beta blocker atenolol, the anticonvulsant 
carbamazepine and the benzodiazepine diazepam and were included as examples of non-illicit 
targets with documented physical properties.  The fact that the three pharmaceuticals showed 
measurable improvements to their detection limits in various biofluids suggests a universal 
improvement for hydrophobic drugs using these methods.  This could be useful for therapeutic 
drug monitoring of more potent drugs where chromatographic techniques are too time consuming 
and expensive. 
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5.5.5 Prototype Cartridge for Implementation of SPE Strip Extraction 
 The aim of this work is to develop a SPE method that can easily be integrated with paper 
spray-MS.  Of the two means of doing this, SPE strip extraction of plasma, urine and oral fluid are 
the simpler option for ease of use.  Due to the viscosity of whole blood multiple waste pads are 
required for extraction and washing making it a more complicated method to implement with paper 
spray-MS than the SPE strip.  SPE strip extraction can be added to a commercially available 
autosampler cartridge with a few modifications (Figure 5.3A-C).  First, the top half of the 
autosampler cartridge can be replaced with a 3D printed version that can snap onto the original 
bottom half of the cartridge (Figure 5A) and fits around the SPE region of the strip when assembled 
(Figure 5B) to channel biofluid and solvent.  The strip is adhered to a thin strip of Delrin plastic 
(Figure 5A) to prevent biofluid from saturating the spray tip beneath during extraction.  After 
extraction, washing, and drying, the waste portion of the strip can be torn along perforation leaving 
behind the SPE region sitting on top of the spray tip ready for analysis (Figure 5C).  This design 
is relatively simple requiring minimal effort to conduct a SPE extraction prior to analysis.  This 
design would work best for plasma or urine extraction as oral fluid has been shown to degrade the 
starch binder. 
5.6 Conclusion 
 Two simple methods to implement solid phase extraction with paper spray mass 
spectrometry were investigated.  A solid consisting of SPE powder and starch was coated onto 
paper or contained in the solvent well of an autosampler cartridge.  The strip was tested to prove 
that analytes would concentrate significantly in the SPE region and then modified for the extraction 
of larger volumes of plasma and urine.  A second method was developed for the direct analysis of 
whole blood which is more viscous and difficult to extract.  Whole blood, plasma, oral fluid and 
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urine were extracted looking at a selection of synthetic cannabinoids, fentanyl analogues and 
pharmaceuticals.  Depending on the analyte and matrix detection limits were improved by a factor 
of five to over a factor of fifty.  Finally, SPE strip extraction was integrated into an autosampler 
cartridge for easy and fast sample extraction of plasma or urine.  This could help facilitate rapid 
screening for NPS from biological fluids. 
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 SELECTION OF 3D PRINTING PLASTICS FOR 
FABRICATION OF MASS SPECTROMETRY DEVICES 
6.1 Abstract 
 Recently, 3D printing has become a cost-effective means for rapid prototyping devices for 
mass spectrometry.  However, the plastic could bind analytes or leach contaminants, leading to 
bias or ionization suppression.  This is a concern for paper spray mass spectrometry (MS) which 
benefits from rapid prototyping but the organic solvents used will make direct contact with the 3D 
printed plastic.  In this work, seven types of commercially available 3D printing plastics were 
evaluated for their impacts on ionization efficiency and non-specific binding of seven 
pharmaceuticals and the protein cytochrome C.  Using those results, plastics for each solvent and 
analyte type were selected to evaluate whether observed changes in ionization efficiency and 
recovery cause changes in detection limits during paper spray mass spectrometry.  These 
experiments determined that a using a paper spray cartridge made from polyethylene terephthalate 
with acetonitrile causes an order of magnitude decrease in detection limits for several analytes 
relative to those with no plastic present.  In all other cases, if no visible change (discoloration or 
deformation) to the plastic occurred, there was a minimal impact on paper spray detection limits.  
The work is concluded with a brief editorial on how to select a 3D printing material based on its 
physical and chemical properties. 
6.2 Introduction 
 3D printing, in which objects are created from digital models layer-by-layer in an additive 
process, has become a useful tool to hobbyists and professionals alike.  Detailed plastic parts and 
prototype devices can now be custom made in hours using machines that are rapidly becoming 
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more sophisticated and affordable1.  This is useful in academia to create low cost and custom parts 
for use during research.  3D printed devices have found use as custom and low cost containers for 
reactions2-3, as microfluidic devices to conduct experiments in a single device4-8, and paired with 
detectors such as mass spectrometers and optical sensors to produce custom parts and 
modifications9-11.  The speed and low cost of 3D printing allows for rapid prototyping and iterative 
design.  This is useful in paper spray mass spectrometry (paper spray MS) which focuses on low 
cost solutions to analytical problems.   
When selecting a material for use with mass spectrometry, it is important to consider if the 
material will impact the final results.  In paper spray MS and other experiments where the printed 
material makes direct contact with organic solvents, the plastic can deform or dissolve based on 
chemical interactions2.  These dissolved components could contribute to decreased ionization 
efficiency and detection limits during paper spray MS12.  In this work, the commercially available 
fused deposition modeling (FDM) 3D printing materials polyethylene terephthalate, 
polypropylene, nylon, acrylonitrile butadiene styrene, polylactic acid, and polycarbonate were 
investigated for solvent compatibility, effects on ionization efficiency, and non-specific binding 
of analytes for both small molecule pharmaceuticals and the protein cytochrome C.  These results 
were used to determine a potential worst and best material for analysis which were then used to 
make a cartridge to contain solvent and paper during paper spray MS.  These cartridges were used 
in a set of experiments to determine the limits of detection to evaluate the impact of the 3D printing 
material.  Finally, these results are discussed with reference to the ease of printing and useful 
properties of these materials. 
132 
 
 
6.3 Materials 
 All the pharmaceuticals and their stable isotopic labels (SIL), except atenolol D7, were 
obtained from Cerilliant (Round Rock, TX, U.S.A.).  Atenolol D7 powder was obtained from CDN 
isotopes (Pointe-Claire, QC, Canada).  HPLC grade methanol, acetonitrile, and formic acid were 
obtained from Fisher Scientific (Waltham, MA, U.S.A).  Bovine and equine cytochrome C came 
from Sigma Aldrich (St, Louis, MO, U.S.A.).  Whatman grade 31 ET chromatography paper was 
obtained from GE Healthcare Life Sciences (Pittsburgh, PA, U.S.A.).  Porous polyethylene 0.6 
mm thick was purchased from Porex (Fairburn, GA, U.S.A.). Carbon rods for sputter coating were 
purchased from SPI Supplies (West Chester, PA, U.S.A.).  3D models were generated in Sketchup 
from Trimble (Synnyvale, CA, U.S.A.).  Test cartridges were printed using an Ender 3 3D printer 
from Creality (Shenzhen, China).  Polyethylene terephthalate filament (PET), polypropylene (PP) 
filament and white polylactic acid (PLA) filament came from Verbatim (Chiyoda, Tokyo, Japan).  
Nylon filament (brand name is ePA) came from eSun (Shenzhen, China), while acrylonitrile 
butadiene styrene (ABS) filament, Colorless PLA filament and polycarbonate plastic was 
purchased from Afinia 3D (Chanhassen, MN, U.S.A.).  Makerbot (New York, NY, U.S.A. and 
Hatchbox (Pomona, CA, U.S.A.), respectively.  All filaments had a diameter of 1.75 mm. 
6.4 Methods 
6.4.1 Evaluating Ionization Suppression and Recovery for Small Molecules 
 Various 3D printing plastics are available depending on the printer being used.  A selection 
of plastics with different polymeric subunits and printing temperatures for FDM 3D printing were 
purchased (properties in table 6.1 structures in figure 6.1). 
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Table 6.1: 3D Printing Plastics.  Printable plastics evaluated for impact on analytical device 
detection limits.  Acetonitrile compatible means that the plastic doesn’t significantly change 
shape when submersed in acetonitrile. (*Brand name of filament). 
 
  
Plastic Abbreviation Polymeric subunit 
Printing 
Temp 
(°C) 
Acetonitrile 
compatible 
Polyethylene 
terephthalate 
PET OCO(C6H4)COOCH2CH2 210-230 Yes 
Polypropylene PP CH(CH3)CH2 220 Yes 
ePA* (nylon) PA6 NH(CH2)5CO 230-260 Yes 
Acrylonitrile 
butadiene 
styrene 
ABS (C3H3N)x (C4H6)y (C8H8)z 260-270 No 
Polylactic 
acid-colorless 
PLA CH(CH3)COO 215 No 
Polylactic 
acid-white 
W-PLA CH(CH3)COO 200-220 No 
Polycarbonate PC O(C6H4)C(CH3)2(C6H4)OCO 240-250 No 
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Figure 6.1: 3D Printing Plastic’s Structures.  Molecular structure for each polymer analyzed. 
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These plastics were cut into 5-10 mm segments then washed three times in milliQ water and 
methanol.  After drying the filament pieces were measured out in 100 mg samples into glass vials.  
A 500 µL aliquot of a methanol or acetonitrile solution containing atenolol, carbamazepine, 
diazepam, fentanyl, gabapentin, hydromorphone and phenylephrine at 100 ng/mL was added to 
each sample.  Samples were vortexed for one hour and left to soak until analysis.  To measure the 
loss of analyte through non-specific binding and potentially reactions with the plastic, hereafter 
collectively referred to as lowered recovery, a 100 µL aliquot was removed from the sample and 
spiked with 5 µL of a 2000 ng/mL internal standard solution consisting of stable isotopic labels 
(SIL) for each of the pharmaceuticals dissolved in methanol.  Controls consisted of aliquots of the 
original solution without any added plastic.  Samples were also spiked at 100 ppm formic acid 
before analysis to aid ionization.  Analysis was carried out by direct injection electrospray 
ionization (ESI) on a Thermo Fisher Scientific Q Exactive Focus Orbitrap mass spectrometer (San 
Jose, CA, U.S.A.) in parallel reaction monitoring mode (PRM).  Samples were analyzed for 1 min 
at 4.5 kV with 10 arbitrary units of sheath gas and a sample flow rate of 10 µL/min.  Ratios were 
calculated based on the area under the curve for the most intense fragment for each analyte and its 
SIL.  Changes in recovery were determined as the average percent change between each sample 
and the controls (N=3).  To evaluate changes in ionization efficiency, aliquots of the plastic extract 
without SIL were injected by autosampler into a stream of solvent, either methanol or acetonitrile 
at 100 ppm formic acid, with SIL being infused at a T-junction by syringe pump.  Solvent flow 
was maintained at 50 µL/min by a G2226A nanopump and G1379A degasser in combination with 
a G1329A autosampler all from Agilent (Santa Clara, CA, U.S.A.).  The syringe pump infused a 
1000 ng/mL SIL solution at 5 µL/min.  MS/MS signal of the SIL for each pharmaceutical was 
measured for 30 seconds before and during the infusion of plastic extract.  Three replicates 
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analyzed for each material.  Ion suppression/enhancement was calculated as a ratio between the 
total area under the curve during the infusion to before the infusion.  Changes in ionization 
efficiency were calculated as the average percent decrease between controls and plastic extract. 
6.4.2 Evaluating Ionization Efficiency and Recovery for Cytochrome C 
 Experiments to evaluate of the impact of 3D printed plastic on recovery and ionization 
efficiency of the protein equine cytochrome C were carried out in the same way as the 
pharmaceuticals with a few changes.  When measuring recovery, plastics were soaked in 3:1 
methanol:water at 1% formic acid and 100 µg/mL of equine cytochrome C.  Ionization efficiency 
was evaluated by injecting aliquots of extracts by autosampler into a stream of solvent with 1 
mg/mL of equine cytochrome C flowed in by T junction.  Measurements for both experiments 
were made by integrating the area under the curve for the most intense peak of the intact protein. 
6.4.3 Changes in Detection Limits 
 The impact of 3D printed plastic on detection limits was investigated for the seven 
pharmaceuticals and cytochrome C.  The plastics with the largest and smallest combined detriment 
to signal for each solvent (acetonitrile, methanol and methanol: water) and analyte type (small 
molecule pharmaceutical or the protein cytochrome C) were selected and used to print paper spray 
cartridges.  These cartridges, shown in figure 6.2, were used to hold a pentagonal wedge of 31ET 
chromatography paper for pharmaceutical analysis or carbon sputtered porous polyethylene for 
protein during paper spray MS13. 
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Figure 6.2: 3D Printed Paper Spray Cartridges.  A) colorless PLA, B) PP and C) PET.  A and B 
contain carbon sputtered porous polyethylene and C) contained Whatman 31ET. 
 
 
 
 
Figure 6.3: Paper Spray Analysis of Cytochrome C.  Paper spray MS analysis of cytochrome C 
using a 3D printed solvent well clipped onto porous polyethylene positioned in front of a mass 
spec inlet. 
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Porous polyethylene was sputter coated with carbon using a Desk V sputtering system (Denton 
Vacuum, Moorestown, NJ, U.S.A.) by pumping down to 10-4 torr and applying 15-30 A to the 
carbon rods13.  Deposition was repeated until a coating of at least 100 nm was reached.  During 
analysis of proteins, only the top part of the cartridges shown in figure 6.2 was clipped to the 
polyethylene to act as a solvent well when positioned in front of the mass spec inlet as shown in 
figure 3.  The assembly was angled downward to aid the flow of solvent along the coated 
polyethylene. 
Paper spray was carried out for 90 seconds at 4.5 kV on an LTQ-XL linear ion trap mass 
spectrometer.  Voltage was applied either by an alligator clip directly attached to the paper or a 
wire inserted into the cartridge.  A holder with minimal plastic contact to the solvent and paper as 
shown in earlier chapters (figure 3.4) was used as a comparison for both small molecules and 
cytochrome C.   
Calibration curves were prepared and analyzed using the different cartridges to evaluate 
changes in detection limits.  For pharmaceuticals, calibration standards were prepared at 0.5, 1, 10, 
25, 100, and 500 ng/mL with 100 ng/mL SIL.  Equine cytochrome C was prepared at 5, 10, 50, 75, 
100, and 150 µg/mL with 100 µg/mL bovine cytochrome C as an internal standard. Ratios between 
the analytes and internal standards were found for each calibration level and a calibration curve 
constructed.  Any data points which were lower than three times the standard deviation of the 
blanks were excluded.  Slopes and Y-intercepts were calculated using linear regression14 with a 
weighting factor of 1/X2.  Limits of detection were set at three times the standard error in the Y-
intercept divided by the slope.   
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6.5 Results and Discussion 
6.5.1 Evaluating Ionization Efficiency and Recovery for Small Molecules 
 3D printing offers rapid prototyping for development of analytical devices.  When 
designing devices that make direct contact with organic solvent, e.g. paper spray MS, it is 
important to ensure that the plastic being used doesn’t negatively impact the detection limits of the 
analysis.  This could be caused by lowered recovery of analytes through non-specific binding, 
reactions with the plastic, or by lower ionization efficiency from leached monomers or other 
contaminants.  To study whether these factors, a variety of commercially available 3D printing 
filaments (the feedstock fed to 3D printers) were cut, washed, and soaked in either acetonitrile or 
methanol.  Two types of PLA, white and colorless, were selected to measure whether coloring 
agents have a noticeable effect.  Acetonitrile was obviously incompatible with certain plastics 
(PLA, ABS and PC) as they visibly swelled, fractured or otherwise deformed when fully 
submersed in the solvent.  These plastic-solvent combinations were not studied further.  PET 
discolored slightly in acetonitrile but appeared otherwise unchanged after 24 hours of submersion, 
so it was further evaluated. 
 To evaluate changes in recovery for small molecules the solvents were spiked with seven 
pharmaceuticals prior to soaking the plastic.  After 24 hours of exposure to the plastic extract 
aliquots were drawn off, spiked with SIL versions of the analytes and analyzed for changes in the 
ratio relative to the original acetonitrile and methanol solutions (figures 6.4A and 6.5A 
respectively). 
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Figure 6.4: Matrix Effects on Pharmaceuticals Caused by 3D Printed Plastics in Acetonitrile.  
Changes in A) recovery and B) ionization efficiency for pharmaceuticals in acetonitrile with 3D 
plastic filament. 
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Figure 6.5: Matrix Effects on Pharmaceuticals Caused by 3D Printed Plastics in Methanol.  
Changes in A) recovery and B) ionization efficiency for pharmaceuticals in methanol with 3D 
plastic filament.  *Fentanyl with ABS plastic showed ~120% ionization enhancement, but, the 
Y-axis wasn’t scaled to prevent visual bias relative to the other results. 
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Looking at the results in figure 6.4, most analytes showed changes in recovery less than 25%.  Two 
specific analytes, atenolol and phenylephrine, showed significant loss when exposed to nylon 
suggesting some kind of interaction with the plastic.  Figure 6.5A demonstrates that no analyte 
showed a greater than 20% change in recovery indicating that methanol likely kept all the analytes 
well solvated in the presence of the different plastics. 
 To analyze effects of plastic on ionization efficiency, extracts of the plastics were 
introduced by autosampler into a stream of solvent which was subsequently mixed with a solution 
of SIL analogs via a T-junction at a constant flow rate.  Changes in SIL signal were measured as 
percent decreases relative to the baseline before the addition of extract, and these ratios were 
compared to injections of plastic free solvent (results for acetonitrile and methanol shown in 
figures 6.4B and 6.5B respectively). Looking at the results for acetonitrile extracts in figure 6.4B, 
there seems to be a general trend of PP having lower impact on ionization efficiency relative to 
the other two plastics.  This result suggests that both PET and nylon leached compounds into the 
solvent that impact ionization to a greater extent than PP.  The contaminants were likely either 
unreacted monomers or some additives used in the manufacture of the filament (added to give the 
plastic useful properties) such as plasticizers, flame retardants and fillers.  Looking at the methanol 
results in figure 6.5B, PP along with white PLA and PET show smaller impacts on ionization 
efficiency for most analytes, while colorless PLA and nylon both appear to have a larger detriment.  
White PLA and uncolored PLA had measurably different results which was unusual especially 
because the white PLA caused less ion suppression even though it had added coloring agents.  The 
white and colorless PLA were from different manufactures, however, suggesting that 
manufacturing methods, raw material sourcing, and additives can have a significant impact on 
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ionization efficiency.  Another anomaly occurred with fentanyl showing measurable ionization 
enhancement from ABS plastic, which none of the other six drug exhibited. 
6.5.2 Evaluating Ionization Suppression and Recovery for Cytochrome C 
 Evaluation of plastic effects on the analysis of cytochrome C was carried out similar to the 
small molecules except that bovine cytochrome C was used as an internal standard instead of a 
stable isotopic label.  In addition, instead of using either pure acetonitrile or methanol, a solvent 
mixture more amenable to protein analysis was used.  The changes in ionization efficiency and 
recovery are shown in figure 6.6. White PLA, PET, and PP resulted in greater than 20% ion 
suppression. None of the plastics showed a significant decrease in recovery.  Oddly, nylon 
exhibited an increase in apparent recovery, suggesting something may have leached out of the 
plastic and caused either ionization enhancement for equine cytochrome C or ionization 
suppression for the internal standard. The mass spectrum for the cytochrome c recovery 
experiment with nylon (figure 6.7A) shows multiple extraneous peaks relative to the same mass 
spectrum for PP (figure 6.7B) or any other plastic tested.  Several of the extraneous peaks (453, 
679 and 701) are known adducts of nylon15. 
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Figure 6.6: Matrix Effects on Cytochrome C Caused by 3D Printed Plastics in Methanol.  
Changes in ionization efficiency and recovery when analyzing cytochrome C solutions with 
added 3D printer filament.  *Equine cytochrome C with nylon showed ~65% recovery, but, the 
Y-axis was not scaled to prevent visual bias relative to the other results. 
 
 
 
Figure 6.7: Mass Spectra of Cytochrome C in Solutions Containing 3D Printing Plastic.  Mass 
spectra of equine and bovine cytochrome C in solutions containing A) nylon and B) PP. 
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6.5.3 Changes in Detection Limits 
 The results indicated there are instances of measurable changes in ionization efficiency and 
recovery with specific combinations of analytes, solvents, and plastics.  The extraction times were 
long, however, and may not reflect the impact in the analytical device where the interaction times 
will be much shorter.  To explore this possibility, paper spray MS cartridges were printed from 
some of the plastics studied here.  Two plastics were selected for each spray solvent based on the 
largest and smallest combined decrease in ionization efficiency and recovery from figures 6.4-6.  
PP showed the least impact on signal for small molecules in both acetonitrile and methanol.  The 
most deleterious plastics were nylon and PLA for acetonitrile and methanol respectively.  A PET 
cartridge was also tested with acetonitrile because it discolored after exposure.  For cytochrome C 
analysis, PP was selected as most likely to cause the largest change and colorless PLA as the plastic 
with the smallest change.  Each solvent was also analyzed just using an alligator clip to hold the 
paper as shown in figure 3.4.  Limits of detection were determined based on linear regression of 
calibration curves and the results for the seven pharmaceuticals are shown in table 6.2 for 
acetonitrile and table 6.3 for methanol. 
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Table 6.2: Paper Spray Detection Limits of Pharmaceuticals Using 3D Printed Cartridges and 
Acetonitrile.  Limits of detection (ng/mL) of pharmaceuticals in acetonitrile analyzed by paper 
spray MS in cartridges made of different 3D printable plastic or with just an alligator clip. 
  Acetonitrile 
  PET PP Nylon Clip 
Atenolol 7 0.2 0.2 0.06 
Carbamazepine 0.8 0.2 0.3 0.3 
Hydromorphone 3 0.2 0.2 0.2 
Gabapentin 6 3 13 5 
Phenylephrine 8 10 8 10 
Fentanyl 0.4 0.7 1 2 
Diazepam 4 0.3 0.3 0.3 
 
Table 6.3: Paper Spray Detection Limits of Pharmaceuticals Using 3D Printed Cartridges and 
Methanol.  Limits of detection (ng/mL) of pharmaceuticals in methanol analyzed by paper spray 
MS in cartridges made of different 3D printable plastic or with just an alligator clip. 
  Methanol 
  PLA PP Clip 
Atenolol 0.09 0.1 0.1 
Carbamazepine 0.2 0.3 0.3 
Hydromorphone 0.1 0.1 4 
Gabapentin 5 5 5 
Phenylephrine 3 3 7 
Fentanyl 0.4 0.2 0.4 
Diazepam 0.5 0.4 0.2 
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Cytochrome C showed little change in detection limits with respect to cartridge material; the limit 
of detection was 2 µg/mL for both colorless PLA and PP and 3 µg/mL when just using an alligator 
clip.  For small molecules, acetonitrile with PET showed at least an order of magnitude increase 
in the detection limits for atenolol, hydromorphone and diazepam.  There was discoloration of 
PET in acetonitrile which could have been the reason for the decrease in ionization efficiency for 
all analytes in figure 6.5A for PET.  Nylon however showed comparable decreases in ionization 
efficiency but didn’t change the detection limits meaning discoloration isn’t the only indicator of 
ionization suppression.  The changes in detection limits for small molecules in acetonitrile did not 
show a consistent trend for all analytes.  Atenolol and phenylephrine both showed decreases in 
recovery of 50-80% from acetonitrile with nylon in figure 6.4A, but only atenolol showed an 
increase in detection limits using the cartridge.  In addition, several analytes showed changes in 
ionization efficiency with PLA plastic and methanol in figure 6.5B, but didn’t show a change in 
detection limits.  The fact that the experiments measured changes in ionization efficiency and 
recovery that didn’t reflect the changes in detection limits is most likely due to the differences in 
how the experiments were run.  When measuring the impacts of the plastics there was at least a 
24-hour incubation time compared to a paper spray MS run which would have had an exposure 
time of less than 2 minutes.  This suggests that exposure time is a relevant factor when choosing a 
plastic.  For the short-term solvent exposure in paper spray MS, any plastic that didn’t melt, deform, 
or discolor when submerged in a solvent didn’t have a noticeable impact on detection limits. 
6.5.4 Other Factors When Selecting a Plastic 
 There are a number of other factors to be considered when selecting a 3D printing plastic 
aside from solvent compatibility.  Ease of printing should be considered when first starting out 
with 3D printing.  PP, for example, is useful for its solvent resistance but is difficult to print any 
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overhanging structures (structures that are printed over gaps in the model).  For other plastics, a 
support material can be printed that serves as a temporary scaffold to hold up the material during 
printing and is remove after printing.  With PP, however, there is a tendency for the heated filament 
to cool too slowly between points on the scaffold, causing the structure to sag and deform during 
printing.  In addition, PP supports tend to fuse with the structure more solidly and must be cut 
away instead of snapped off. 
 Many plastics also have special requirements to be printed successfully.  A major 
consideration is that most 3D printers have a PTFE tube in the heated extruder to feed the filament 
to the nozzle.  This tubing will start to degrade at high temperatures (~250-260°C) and will leave 
blackened specs in the plastic as it prints.  This residue could interfere with the print quality, 
potentially cause problems with experiments, or damage the 3D printer.  To avoid this, all-metal 
print head can be installed.  Additionally, most filaments will deform if cooled too fast.  Many 3D 
printers have an enclosed printing area that is heated either passively (chamber is well insulated) 
or actively (has an added heating element) to prevent parts from warping or detaching from the 
build plate.  PC in particular requires an elevated build chamber temperature to print correctly, and 
a 3D printer typically has to be specifically designed to print PC.  Finally, filaments like nylon 
absorb water from the air and swell which can cause problems during printing.  It is useful to store 
these filaments with desiccant between printing jobs or to bake them at 70-100°C for a few hours 
to dry them out prior to printing.  Most manufacturers include a list of special printing instructions 
with the filament.  Suggested printing temperatures can vary from manufacturer to manufacturer. 
 When selecting a material for a device, it is also important to consider its physical 
properties.  PP, nylon and PET can be slightly flexible at room temperature if the part is thin, 
whereas PLA, ABS and PC are more rigid.  Each plastic becomes soft and bendable at different 
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temperatures (indicated in table 1), an important consideration if the part will be exposed to 
elevated temperatures.  Organic solvents can discolor, deform, or otherwise melt specific plastics 
which can lead to poor durability in addition to potentially hurting detection limits as discussed 
earlier.  If solvent compatibility isn’t an issue, PLA is generally the easiest plastic to print 
successfully.  PP is more difficult to print, but resistant to many organic solvents.  If a more 
complicated device with overhangs is desired, PET or nylon are more resistant than PLA to 
different solvents, but easier to print than PP.  ABS and PC are more rigid with higher temperature 
resistance but can be difficult to print unless the 3D printer being used is specifically designed to 
print those plastics. 
 The work and discussion presented here focused on fused deposition modeling 3D printing 
as it is the most cost-effective method to begin 3D printing.  Stereolithography (SLA) 3D printers, 
which use photocurable resins, tend to be more expensive and more difficult to use, but can often 
print at higher resolution and provide smoother surface finishes. This type of printing was 
investigated briefly for this work as well, but the cured methacrylate resin crumbled after soaking 
24 hours in methanol or acetonitrile and was therefore deemed unsuitable for solvent exposure 
during MS analysis.   
6.6 Conclusion 
 The work presented here outlined a series of experiments to determine whether long term 
exposure of 3D printable plastic to organic solvents could hurt the detection limits of analytical 
methods and whether those results translated into higher detection limits for paper spray mass 
spectrometry.  A selection of small molecule pharmaceuticals in acetonitrile or methanol and the 
protein cytochrome C in a methanol-water solution were investigated.  It was determined that 
several plastics were deformed or discolored by acetonitrile.  With both solvents, and in specific 
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combinations of plastic, solvent, and analyte, there were measurable decreases in recovery and 
ionization efficiency of the analytes after 24 hours of exposure.  These results were used to select 
the best and worst materials for paper spray mass spectrometry devices, and the limits of detection 
were determined using cartridges printed in these materials.  The interaction between organic 
solvent and plastic was much shorter in these experiments; only acetonitrile with PET showing a 
measurable decrease in detection limits relative to analysis using just an alligator clip.  This 
suggested that as long as the solvent being used doesn’t discolor or deform the plastic, brief 
interactions will not affect the detection limits during the analysis of pharmaceuticals or the protein 
cytochrome C during paper spray mass spectrometry.  This gives the user greater freedom to 
consider other factors important to 3D printing analytical devices 
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